Breast Cancer Type 1 Susceptibility Protein Measurement,Contralateral breast cancer,Tubular breast cancer,stage IIIA breast cancer,Locally advanced breast cancer,stage IIIB breast cancer,breast cancer diagnosis,estrogen receptor-positive breast cancer,bilateral breast cancer,stage IA breast cancer,progesterone receptor-negative breast cancer,Suspected breast cancer,progesterone receptor-positive breast cancer,Mucinous breast cancer,Lumpectomy (breast cancer),"cellular diagnosis, breast cancer",Family history of breast cancer,HER2-negative breast cancer,contralateral breast cancer,Breast Cancer Model,breast cancer prevention,Breast Cancer Surveillance Consortium,hormone receptor/growth factor receptor-negative breast cancer,allogeneic GM-CSF-secreting breast cancer vaccine,Breast cancer metastatic,Invasive ductal breast cancer,estrogen receptor-negative breast cancer,"stage, breast cancer",Breast Cancer Radiotherapy,Breast cancer invasive NOS,Advanced breast cancer diagnosis
HER2-negative breast cancer,Patients,Diagnostic radiologic examination,Pharmacotherapy,Puncture biopsy,Operative Surgical Procedures,Acquired Immunodeficiency Syndrome,ESR1,Breast Carcinoma,,ROS1 gene|ROS1,radical mastectomy,sirolimus,Mucin-2 Staining Method,Interstitial brachytherapy,MicroRNAs,Development of the breasts,Pharmacotherapy,Prognosis good,Invasive ductal breast cancer,Risk Reduction,,Molecular Targeted Therapy,Immunomodulators,breast cancer prevention,Pharmacotherapy,Antineoplastic Agents,Hypertensive disease,contralateral breast cancer,breast cancer diagnosis,"Receptors, Progesterone"
,clonality,Radial scar,Mastectomy,paclitaxel,Intra-Arterial Infusions,Sexual function,Neoadjuvant Therapy,Malignant neoplasm of breast,,Carpal Tunnel Syndrome,Diagnosis,COG2,Invasive ductal breast cancer,Brachytherapy,,Ovarian Carcinoma,pembrolizumab,Breast Carcinoma,,Estrogen Antagonists,,Biological Response Modifiers,,breast cancer prevention,Pharmacotherapy,Trans Fatty Acids,Radiation therapy,contralateral breast cancer,Contralateral breast cancer,estrogens
,exemestane,Diagnostic radiologic examination,Pharmacotherapy,Pharmacotherapy,Pharmacotherapy,Upper Extremity,Triple Negative Breast Neoplasms,Core needle biopsy,,Woman,Biopsy,TRIP6 gene|TRIP6,erbB-2 Receptor|ERBB2,Woman,,Consultation,Pharmacotherapy,TP53 gene|TP53,,Treatment Protocols,,Biological Response Modifiers,,breast cancer diagnosis,Operative Surgical Procedures,"ORF74 protein, Human herpesvirus 8",fluorodeoxyglucose,,Family history of breast cancer,
,Tamoxifen,Hyaluronic Acid,Immunologic Adjuvants,Pharmacotherapy,Treatment Protocols,Advice,Body tissue,Males,,progesterone receptor-positive breast cancer,Injection procedure,progesterone receptor-negative breast cancer,Pharmacotherapy,,,Intervention regimes,Pharmacotherapy,Histamine H1 Antagonists,,cancer prevention,,Molecular Targeted Therapy,,,Operative Surgical Procedures,"ORF74 protein, Human herpesvirus 8","ST13 protein, human|ST13",,Family history of breast cancer,
,BRCA2 gene|BRCA2,Hyaluronic Acid,high-dose chemotherapy,Pre-operative chemotherapy,Neoadjuvant Therapy,Upper Extremity,Neoplasms,Pharmacotherapy,,Malignant neoplasm of breast,radical mastectomy,Malignant neoplasm of breast,Pharmacotherapy,,,Malignant neoplasm of breast,Treatment Protocols,Histamine H1 Antagonists,,Intervention regimes,,Current Therapy,,,Human tissue,GPER1 gene|GPER1,Ultrasonography,,breast cancer prevention,
,Mastectomy,Connective Tissue,Therapeutic procedure,Pharmacotherapy,Doxorubicin,Health System,Biological Markers,Reconstructive Surgical Procedures,,,Woman,,Body tissue,,,Malignant neoplasm of breast,Pharmacotherapy,Contralateral Prophylactic Mastectomy,,Pharmaceutical Preparations,,Targeted Therapy,,,Operative Surgical Procedures,paclitaxel,Transcriptional Activation,,Invasive ductal breast cancer,
,Malignant neoplasm of breast,Stroma,Curative Surgery,Complete excision,Pharmacotherapy,Early Diagnosis,estrogens,Bilateral mastectomy,,,Mammography,,Assay,,,Screening mammography,Pharmacotherapy,Histamine H1 Antagonists,,Dietary Modification,,palbociclib,,,Genes,GPER1 gene|GPER1,Detection,,Invasive ductal breast cancer,
,Malignant neoplasm of breast,Carcinoma,Pharmacotherapy,other medicated shampoos in ATC,Cyclophosphamide,Carrier of disorder,Core needle biopsy,Endocrine therapy,,,"technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane",,Anatomic Site,,,Woman,cisplatin,Breast Cancer Radiotherapy,,Woman,,Hormone Therapy,,,Operative Surgical Procedures,EMP2 gene|EMP2,GRHL3,,,
,Tamoxifen,16q,Pharmacotherapy,Pharmacotherapy,Methotrexate,Light microscopy,Oncogenes,Breast,,,Operative Surgical Procedures,,Macrophage Activation Syndrome,,,Malignant neoplasm of breast,"CD69 protein, human|CD69",BRCA2 gene|BRCA2,,Tamoxifen,,palbociclib,,,Neoplasm Metastasis,EMP2 gene|EMP2,Magnetic Resonance Imaging,,,
,Syndrome,Noninfiltrating Intraductal Carcinoma,Estrogen Receptors,Pharmacotherapy,Fluorouracil,Carrier of disorder,Neoplasms,osteosarcoma,,,Injection procedure,,Patients,,,Breast cancer invasive NOS,doxorubicin liposome,Mutation,,Selective Estrogen Receptor Modulators,,Hormone Therapy,,,Therapeutic procedure,doxorubicin,Operative Surgical Procedures,,,
,Carrier of disorder,Secondary malignant neoplasm of axilla,Therapeutic procedure,paclitaxel,Medullary,Carrier of disorder,Phosphatidylinositide 3-Kinase Inhibitor,Pharmacotherapy,,,Diagnosis,,Lymph Node Metastasis,,,Breast cancer invasive NOS,cisplatin,Magnetic resonance imaging of breast,,Intervention regimes,,Hormone Therapy,,,Phosphatidylethanolamine Binding Protein,PBX1 gene|PBX1,Lesion,,,
,Malignant neoplasm of breast,Medullary,Axilla,Pharmacotherapy,Pharmacotherapy,Magnetic Resonance Spectroscopy,Phosphatidylinositide 3-Kinase Inhibitor,Mastectomy,,,Supportive care,,Woman,,,Malignant neoplasm of breast,capecitabine,Breast Cancer Radiotherapy,,Treatment Protocols,,First line treatment,,,mitogen-activated protein kinase p38,Pharmacotherapy,Radioisotope scan of bone,,,
,Encounter due to genetic counseling,Radiation therapy,Lung,Trastuzumab Regimen,Pharmacotherapy,Assisting,ESR1,Neoplasm,,,Radionuclide Imaging,,post surgery radiation therapy,,,dietary intervention,Targeted Therapy,TP53 gene|TP53,,Clinical Research,,palbociclib,,,Operative Surgical Procedures,Pharmacotherapy,tomography,,,
,Tamoxifen,Operative Surgical Procedures,Therapeutic procedure,Pharmacotherapy,adjuvant therapy,Medical Imaging,Hormone Therapy,Neoplasm,,,Ultrasonography,,post surgery radiation therapy,,,Woman,bevacizumab,BRCA2 gene|BRCA2,,Tamoxifen,,palbociclib,,,Pharmacotherapy,Duration,Magnetic Resonance Imaging,,,
,adjuvant therapy,Malignant neoplasm of breast,"Chemotherapy, Adjuvant",Pharmacotherapy,"3,4-Methylenedioxyamphetamine",Medical Devices,Oncogenes,Mothers,,,Ultrasonography,,Malignant neoplasm of breast,,,Underinsured,Taxanes,GPER1 gene|GPER1,,"Clinical Trials, Phase III",,inhibitors,,,Tissue specimen,Hepatocyte Growth Factor,Ultrasonography,,,
,Tamoxifen,Body tissue,"Radiotherapy, Adjuvant",Pharmacotherapy,Pharmacotherapy,Malignant neoplasm of breast,Phosphatidylinositide 3-Kinase Inhibitor,Malignant neoplasm of breast,,,Health Care,,Hemorrhage,,,ADAMTS2 gene|ADAMTS4|ADAMTS2,Pharmacotherapy,ATM,,Pharmaceutical Preparations,,sacituzumab govitecan,,,Mastectomy,doxorubicin,Radiation therapy,,,
,BRCA1 gene|BRCA1,,Radiation therapy,docetaxel,Modified radical mastectomy,Radiopharmaceuticals,ESR1,Neoplasm,,,Biopsy,,Pharmacotherapy,,,Participant,Bevacizumab/Capecitabine,"GPER protein, human|GPER1",,Malignant neoplasm of breast,,letrozole,,,"Chemotherapy, Adjuvant",GPER1 gene|GPER1,Therapeutic procedure,,,
,Pharmaceutical Preparations,,Ethinyl Estradiol,Pharmacotherapy,high-dose chemotherapy,Computer Aided Detection Systems,Neoadjuvant Therapy,Ovarian Carcinoma,,,Diagnostic radiologic examination,,Pharmacotherapy,,,Malignant neoplasm of breast,Second line treatment,Single Nucleotide Polymorphism,,Selective Estrogen Receptor Modulators,,sacituzumab govitecan,,,Immunohistochemistry,doxorubicin,PDPN,,,
,breast cancer diagnosis,,Radiation therapy,docetaxel,Autologous Stem Cell Transplantation,Bone Diseases,Oncogenes,Syndrome,,,Percutaneous needle biopsy,,Extracellular Vesicles,,,Woman,Capecitabine/Vinorelbine,ATM,,Genistein,,letrozole,,,"Tissue, Fresh",EMP2 gene|EMP2,PDPN,,,
,Tamoxifen,,Radiation therapy,Aromatase Inhibitors,high-dose chemotherapy,Mammography,cytidylyl-3'-5'-guanosine,Bilateral mastectomy,,,Mammography,,,,,Risk Assessment,Adjuvant Therapy,Single Nucleotide Polymorphism,,Therapeutic procedure,,palbociclib,,,"Chemotherapy, Adjuvant",Pharmacotherapy,Imaging Techniques,,,
,Tamoxifen,,Therapeutic procedure,EC Breast Regimen,high-dose chemotherapy,Mammography,ARID1A gene|ARID1A,Operative Surgical Procedures,,,Detection,,,,,Malignant Neoplasms,AZD5363,Prune Belly Syndrome,,Aromatase Inhibitors,,First line treatment,,,Operative Surgical Procedures,paclitaxel,Operative Surgical Procedures,,,
,Malignant neoplasm of breast,,,Excision of axillary lymph nodes group,Mitoxantrone,Procedures,ARID1A gene|ARID1A,Peutz-Jeghers Syndrome,,,Scanning,,,,,Malignant neoplasm of thyroid,bevacizumab,Contralateral Prophylactic Mastectomy,,Finasteride,,sacituzumab govitecan,,,Breast,PBX1 gene|PBX1,Radiation therapy,,,
,Fenretinide,,,Neoadjuvant Therapy,Treatment Protocols,Therapeutic procedure,zoledronic acid,Disease,,,Diagnosis,,,,,Malignant neoplasm of breast,Pharmacotherapy,Pathogenic,,Advice,,Second line treatment,,,Secondary malignant neoplasm of lymph node,PBX1 gene|PBX1,Detection,,,
,Tamoxifen,,,Extraction,Carboplatin,Radionuclide Imaging,PGR gene|PGR,Clinical finding,,,Patient referral,,,,,,Second line treatment,Pathogenic,,Woman,,Hormone Therapy,,,MDM2 gene|MDM2,paclitaxel,Breast Self-Examination,,,
,Therapeutic procedure,,,Neoadjuvant Therapy,Thiotepa,letrozole,RNLS gene|RNLS,Clomiphene,,,Urgent referral,,,,,,capecitabine,Aromatase Inhibitors,,Hydroxymethylglutaryl-CoA Reductase Inhibitors,,Antineoplastic Agents,,,Secondary malignant neoplasm of lymph node,sphingosine kinase-1,Detection,,,
,Population Group,,,"Mastectomy, Subcutaneous",trastuzumab,Self Care,ARID1A gene|ARID1A,Neoplasm,,,Cytological Techniques,,,,,,Antineoplastic Agents,BRCA Mutation Analysis,,Woman,,Hormone Therapy,,,Neoplasm,Pharmacotherapy,Medical exam,,,
,Tamoxifen,,,Pharmacotherapy,TP53 gene|TP53,trastuzumab,epithelial to mesenchymal transition,Neoplasm,,,Core needle biopsy,,,,,,Pharmacotherapy,Diphosphonates,,Mothers,,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,,,Invasive Carcinoma,Tumor Progression,Disease,,,
,Tamoxifen,,,Pharmacotherapy,,Mandibular right first molar abutment,tamoxifen,Malignant neoplasm of breast,,,,,,,,,Pharmacotherapy,Patients,,Surveys,,Aromatase Inhibitors,,,MDM2 gene|MDM2,FGFBP1 gene|FGFBP1,"Tomography, Emission-Computed, Single-Photon",,,
,Radiation therapy,,,Neoadjuvant Therapy,,Malignant Neoplasms,Dietary Iron,Neoplasm Metastasis,,,,,,,,,Pharmacotherapy,Radiation,,Tamoxifen,,abemaciclib,,,Excision,Radon,Diagnostic Neoplasm Staging,,,
,Synthetic antiestrogen,,,TOP2A gene|TOP2A,,Diagnosis,"TNFRSF11A protein, human|TNFRSF11A",Malignant neoplasm of breast,,,,,,,,,Pharmacotherapy,Malignant Neoplasms,,dietary intervention,,Hormone Therapy,,,Monocyte Chemoattractant Protein-1,Genes,Axillary lymph node group,,,
,Tamoxifen,,,Aromatase Inhibitors,,Health System,SLC3A2 gene|SLC3A2,Gene Abnormality,,,,,,,,,Pharmacotherapy,Right-Sided Breast Neoplasms,,Therapeutic procedure,,,,,Neoplasm,AGR2,Axillary lymph node group,,,
,Malignant neoplasm of breast,,,EC Breast Regimen,,Immunity,Estrogen Receptors,Malignant neoplasm of breast,,,,,,,,,durvalumab,Sporadic Breast Carcinoma,,Pharmacotherapy,,,,,Proliferating Cell Nuclear Antigen,Tumor Progression,Dissection,,,
,Tamoxifen,,,Pharmacotherapy,,Immunohistochemistry,"TNFRSF11A protein, human|TNFRSF11A",TP53 gene|TP53,,,,,,,,,Second line treatment,Bilateral mastectomy,,Noninfiltrating Intraductal Carcinoma,,,,,"Receptors, Steroid",rivaroxaban,Primary Neoplasm,,,
,Breast surgery,,,Pharmacotherapy,,Malignant neoplasm of breast,Hormone Therapy,TP53 gene|TP53,,,,,,,,,Hormone Therapy,Contralateral Prophylactic Mastectomy,,Clinical Research,,,,,Large Intestine,epsin,Biopsy,,,
,Genitourinary Cancer,,,TOP2A gene|TOP2A,,Cessation of life,Pharmacotherapy,Ethanol,,,,,,,,,Adjuvant Therapy,Left breast,,Tamoxifen,,,,,"Tissue, Paraffin",Targeted Therapy,"Tomography, Emission-Computed, Single-Photon",,,
,Menopausal Status,,,Pharmacotherapy,,Diabetes,Pharmacotherapy,Alcohol consumption,,,,,,,,,bevacizumab,Diffusion weighted imaging,,Woman,,,,,"Receptors, Steroid|EREG|ESR1",NF-kappa B,Axillary lymph node group,,,
,adjuvant therapy,,,Mastectomy,,Clinical Management,Malignant neoplasm of breast,Ultrasonography,,,,,,,,,vinorelbine,Diffusion weighted imaging,,Tamoxifen,,,,,"Receptors, Steroid",estrogen receptor-positive breast cancer,Axillary Lymph Node Dissection,,,
,Menopausal Status,,,removal technique,,Malignant neoplasm of endometrium,Aromatase Inhibitors,Malignant Neoplasms,,,,,,,,,Pharmacotherapy,Smoking,,Woman,,,,,Lymph node excision,rivaroxaban,Aromatase,,,
,Tamoxifen,,,Pharmacotherapy,,"Spectrum Analysis, Raman",ESR1,Fatty acid glycerol esters,,,,,,,,,Second line treatment,Contralateral Prophylactic Mastectomy,,Woman,,,,,Mastectomy,E2F5 gene|E2F5,Obesity,,,
,SCPEP1,,,removal technique,,Symptoms,Pharmacotherapy,Malignant neoplasm of breast,,,,,,,,,Taxanes,Ultrasonography,,AR gene|AR,,,,,Morphometric analysis,cytokine,Magnetic Resonance Imaging,,,
,Tamoxifen,,,Pharmacotherapy,,HIGH SENSITIVITY,Androgen Receptor,Mammography,,,,,,,,,Pharmacotherapy,Mammography,,anastrozole,,,,,Monoclonal Antibodies,Interferon Regulatory Factor 8,Positron-Emission Tomography,,,
,Patients,,,Chemotherapy cycle,,Patients,IMPACT gene,Oleic Acid,,,,,,,,,vinorelbine,Data Collection,,Woman,,,,,Infiltration,Infiltration,Positron-Emission Tomography,,,
,Tamoxifen,,,Pharmacotherapy,,Diagnosis,Phosphatidylinositide 3-Kinase Inhibitor,Mammography,,,,,,,,,trebananib,Mutation,,Woman,,,,,Morphometric analysis,TWIST1 gene|TWIST1,Mammography,,,
,bilateral breast cancer,,,Mastectomy,,Contralateral breast cancer,RNLS gene|RNLS,Malignant neoplasm of breast,,,,,,,,,AKR1A1 wt Allele,Breast Therapy,,Hyperplasia,,,,,Body tissue,PRKCQ gene|PRKCQ,Excision,,,
,Pharmacotherapy,,,Aneuploidy,,Hormone replacement therapy,tamoxifen,Prolactinoma,,,,,,,,,Pharmacotherapy,Moderate risk,,Underserved Population,,,,,Body tissue,Infiltration,Gamma Cameras,,,
,Malignant neoplasm of breast,,,Mastectomy,,Hormone replacement therapy,Phosphatidylinositide 3-Kinase Inhibitor,Malignant neoplasm of breast,,,,,,,,,talazoparib,ATM,,Estrogen Antagonists,,,,,Body tissue,Prognosis bad,Positron-Emission Tomography,,,
,Radiation therapy,,,Sentinel Lymph Node Biopsy,,follow-up,First line treatment,Operative Surgical Procedures,,,,,,,,,Chemotherapy Regimen,Magnetic resonance imaging of breast,,Tamoxifen,,,,,Body tissue,Syndecan-4,Individual,,,
,breast cancer diagnosis,,,Aneuploidy,,"Hospitals, County",Hormone Therapy,TP53 gene|TP53,,,,,,,,,Pharmacotherapy,Risk Analysis,,Tamoxifen,,,,,"Spectrophotometry, Atomic Absorption",Drug resistance,Vitamin D,,,
,Tamoxifen,,,Mastectomy,,Group Therapy,everolimus,Radiation therapy,,,,,,,,,cisplatin,Magnetic resonance imaging of breast,,agonists,,,,,Tumor Antigens,Mammary Ductal Carcinoma,Woman,,,
,Tamoxifen,,,Sentinel Lymph Node Biopsy,,Mammography,tamoxifen,Individual,,,,,,,,,First line treatment,Magnetic resonance imaging of breast,,Clinical Research,,,,,Metallothionein,Estrogen Receptor alpha,Stem Cell Factor,,,
,Tamoxifen,,,Mastectomy,,Biopsy,tamoxifen,Radiation therapy,,,,,,,,,Second line treatment,Pharmacotherapy,,Chemopreventive Agent,,,,,Proteins,High Grade Malignant Neoplasm,Disease,,,
,anastrozole,,,Pharmacotherapy,,Ovarian Carcinoma,Pharmacotherapy,Open wounds NOS,,,,,,,,,Carboplatin/Paclitaxel,Physical function,,indole-3-carbinol,,,,,Operative Surgical Procedures,Transferrin,African race,,,
,Fenretinide,,,Mastectomy,,Mammography,ESR1,Transcatheter arterial embolization,,,,,,,,,Cytotoxic Chemotherapy,Sporadic Breast Carcinoma,,Disease,,,,,Radiation therapy,Oxytocin Receptor,Magnetic Resonance Imaging,,,
,Malignant neoplasm of breast,,,Pharmacotherapy,,Malignant neoplasm of prostate,Selective Estrogen Receptor Down Regulator,Pharmacotherapy,,,,,,,,,thymidine kinase 1,Physical function,,"Diet, Fat-Restricted",,,,,Forehead,Human Age Group,Hispanics,,,
,Patients,,,Pharmacotherapy,,Therapeutic procedure,RET,Axillary lymph node group,,,,,,,,,Second line treatment,Mammographic Breast Density,,Disseminated Malignant Neoplasm,,,,,Sodium measurement,sesamol,Therapeutic procedure,,,
,Neoplasm Metastasis,,,paclitaxel,,Advance,"CCNE1 protein, human|CCNE1",Lung,,,,,,,,,Second line treatment,Magnetic Resonance Imaging,,indole-3-carbinol,,,,,"SLC5A5 protein, human|SLC5A5",Assay,Caucasoid Race,,,
,Fenretinide,,,Pharmacotherapy,,"Leukemia, Myelocytic, Acute","CCNE1 protein, human|CCNE1",adjuvant therapy,,,,,,,,,Combined Modality Therapy,Woman,,Clinical Research,,,,,Cadherins,EDAR gene|EDAR,Neoplasm,,,
,Woman,,,Pharmacotherapy,,Malignant neoplasm of breast,PGR gene|PGR,Malignant Neoplasms,,,,,,,,,cisplatin,TP53,,Therapeutic procedure,,,,,Metallothionein,"Chromosomes, Human, Pair 2",Fine needle aspiration biopsy,,,
,Woman,,,hydrogen peroxide,,"Leukemia, Myelocytic, Acute",FOXM1 gene|FOXM1,Contralateral breast cancer,,,,,,,,,olaparib,Magnetic Resonance Imaging,,Raloxifene,,,,,Body tissue,Stroma,PAXIP1,,,
,Tamoxifen,,,Neoadjuvant Therapy,,Diagnosis,Pharmacotherapy,Tumor Antigens,,,,,,,,,First line treatment,Prophylactic Mastectomy,,Tamoxifen,,,,,PGR gene|PGR,WDR43 gene|WDR43,Dermatomyositis,,,
,Malignant Neoplasms,,,Neoadjuvant Therapy,,thermography,Aromatase Inhibitors,Hodgkin Disease,,,,,,,,,Pharmacotherapy,Risk Scores,,Therapeutic procedure,,,,,maspin|SERPINB5,Malignant neoplasm of breast,BIRC5 gene|BIRC5,,,
,Patients,,,hydrogen peroxide,,Scanning,fulvestrant,Antigens,,,,,,,,,palbociclib,Detection,,Clinical Research,,,,,Human tissue,PLB1 gene|PLB1,Fatty-acid synthase,,,
,Radiation therapy,,,paclitaxel,,Assessment procedure,Ultrasonography,Patients,,,,,,,,,palbociclib,CHEK2 gene|CHEK2,,Pharmaceutical Preparations,,,,,"PTTG1 protein, human|PTTG1",RAC2 gene|RAC2,SHARPIN,,,
,Malignant neoplasm of breast,,,Pharmacotherapy,,Reconstructive Surgical Procedures,Triple Negative Breast Neoplasms,Estrogen Receptors,,,,,,,,,Carcinomatosis,Tomotherapy,,Tamoxifen,,,,,Neoplasm,Estrogen Receptor alpha,DHX32,,,
,Mammaplasty,,,Pharmacotherapy,,Carrier of disorder,ESTROGEN RESISTANCE,Malignant neoplasm of breast,,,,,,,,,ribociclib,PALB2 gene|PALB2,,Estrogen Antagonists,,,,,"PTTG1 protein, human|PTTG1",Androgen Receptor,VEGFA,,,
,Fenretinide,,,Pharmacotherapy,,Contralateral breast cancer,Hormone Therapy,Neoplasm,,,,,,,,,ribociclib,Genes,,Tamoxifen,,,,,Proto-Oncogene Proteins c-akt|AKT1,AMACR wt Allele,Mitogen-Activated Protein Kinases,,,
,Malignant neoplasm of breast,,,Biomarker Analysis,,IMMUNOHISTOCHEMICAL,"KRT5 protein, human|KRT5",Mammography,,,,,,,,,Pharmacotherapy,BRCA2 gene|BRCA2,,Tamoxifen,,,,,Estrogens,Body tissue,NFKB1,,,
,anastrozole,,,Reconstructive Surgical Procedures,,Carcinogenesis,Aromatase Inhibitors,Silicone gel implant,,,,,,,,,Pharmacotherapy,Magnetic Resonance Imaging,,Rattus norvegicus,,,,,Tamoxifen,SLC26A3 gene|SLC26A3,Sentinel Lymph Node Biopsy,,,
,anastrozole,,,Mammaplasty,,thermography,Tumor Suppressor Genes,Gynecomastia,,,,,,,,,Pharmacotherapy,Surviving free of recurrence of neoplastic disease,,Raloxifene,,,,,Metallothionein,GTF2H1 gene|GTF2H1,Sentinel Lymph Node Biopsy,,,
,Therapeutic procedure,,,Biomarker Analysis,,Hodgkin Disease,tamoxifen,"Carcinoma, Lobular",,,,,,,,,trastuzumab,IMPACT gene,,Tamoxifen,,,,,"Receptor, Angiotensin, Type 1",ACSL4 gene|ACSL4,SPDEF,,,
,Ultrasonography,,,First line treatment,,follow-up,tamoxifen,member,,,,,,,,,Diagnosis,Increased risk,,Tamoxifen,,,,,Local excision,"FRAP1 protein, human|MTOR",gene polymorphism,,,
,Tamoxifen,,,TEKT4 gene|TEKT4,,Institutes,Androgen Receptor,Neoplasm,,,,,,,,,Carcinomatosis,caveolin 1,,Malignant neoplasm of breast,,,,,Vascular Endothelial Growth Factor D|VEGFA,everolimus,Sentinel Lymph Node Biopsy,,,
,Tamoxifen,,,Pharmacotherapy,,Medical Care Team,Tumor Suppressor Genes,"Receptors, Steroid",,,,,,,,,Pharmacotherapy,Secondary malignant neoplasm of female breast,,Tamoxifen,,,,,Vascular Endothelial Growth Factor D|VEGFA,everolimus,Lymph node excision,,,
,Therapeutic procedure,,,Pain management,,Digital mammography,tamoxifen,PGR gene|PGR,,,,,,,,,goserelin,Multiparametric Magnetic Resonance Imaging,,Biological Assay,,,,,Radiation therapy,Androgen Receptor,Disease,,,
,Mammography,,,Reconstructive Surgical Procedures,,Free prostate-specific antigen,fulvestrant,Estrogens,,,,,,,,,CD68,Dynamic Contrast-Enhanced Magnetic Resonance Imaging,,Clinical Research,,,,,N-Myc Downstream Regulated Protein 1|MYC,Diabetes,Operative Surgical Procedures,,,
,Mammography,,,Insulin Resistance,,Magnetic Resonance Imaging,everolimus,Family,,,,,,,,,talazoparib,Pathogenic Variant,,Tamoxifen,,,,,Patients,Ki67 Measurement,Neoplasm,,,
,Tamoxifen,,,"Radiotherapy, Intensity-Modulated",,Free prostate-specific antigen,Pharmacotherapy,TP53 gene|TP53,,,,,,,,,Activating ERBB2 Mutation,Pathogenic Variant,,research study,,,,,Western Blot,Carcinogens,CA-15-3 Antigen,,,
,Human,,,TEKT4 gene|TEKT4,,Patients,Pharmacotherapy,Family,,,,,,,,,CD163,Patients,,Tamoxifen,,,,,Cell Nucleus,Carcinogenesis,Glycoproteins,,,
,Selective Estrogen Receptor Modulators,,,wound care,,Mammography,SLC3A2 gene|SLC3A2,TP53 gene|TP53,,,,,,,,,erbB-2 Receptor|ERBB2,Mastectomy,,Fenretinide,,,,,Lymphatic Metastasis,Estrogen receptor positive,Axilla,,,
,Tamoxifen,,,IMPACT gene,,Ultrasonography,Pharmacotherapy,Disease,,,,,,,,,"T-Cell Surface Glycoprotein CD4, human|CD4",Detection,,Chemoprevention,,,,,KCNMA1,PLXNB3 gene|PLXNB3,Biopsy,,,
,Woman,,,Neoadjuvant Chemotherapy,,Augmentation mammoplasty,Phosphatidylinositide 3-Kinase Inhibitor,TP53 gene|TP53,,,,,,,,,FOXP3 gene|FOXP3,Hormone Therapy,,Tamoxifen,,,,,Ovary,"TNFRSF11A protein, human|TNFRSF11A",Hand,,,
,Tamoxifen,,,Pharmacotherapy,,Hormone replacement therapy,IMPACT gene,Somatic mutation,,,,,,,,,Breast Cancer Type 1 Susceptibility Protein Measurement,,,Estrogen Antagonists,,,,,RAB25,Estrogen receptor positive,Neoplasm,,,
,anastrozole,,,Pharmacotherapy,,Gadolinium DTPA,ESR1,Microsatellite Instability,,,,,,,,,erbB-2 Receptor|ERBB2,,,Clinical Research,,,,,RAB25,estrogen receptor-positive breast cancer,Neoplasm,,,
,Tamoxifen,,,Pharmacotherapy,,Malignant neoplasm of breast,Estrogen Receptor alpha,Xeromammography,,,,,,,,,Pharmacotherapy,,,"Clinical Trials, Phase II",,,,,Endometrium,FANCM gene|FANCM,Dissection,,,
,Therapeutic procedure,,,Anthracyclines,,Breast,exemestane,Mammography,,,,,,,,,paclitaxel,,,Raloxifene,,,,,VEGF gene|VEGFA,Biological Markers,Excision,,,
,Arimidex,,,Mastectomy,,electrical measurement,SLC7A8 gene|SLC7A8,Family member,,,,,,,,,chlorodihydroxypyridine/potassium oxonate/tegafur,,,Tamoxifen,,,,,cyclophosphamide/fluorouracil/methotrexate protocol,Matrix Metalloproteinases,Radiation therapy,,,
,Tamoxifen,,,Pharmacotherapy,,Diagnosis,Neoadjuvant Therapy,Peutz-Jeghers Syndrome,,,,,,,,,Pharmacotherapy,,,Clinical Research,,,,,Rho GDIalpha,Matrix Metalloproteinases,Dissection,,,
,Malignant Neoplasms,,,Pre-operative chemotherapy,,fluorophore,Polysaccharides,Patients,,,,,,,,,talazoparib,,,genetic aspects,,,,,Body tissue,AMACR wt Allele,Radiation therapy,,,
,Treatment Protocols,,,"Hyperthermia, Local",,Neoplasm,SLC7A8 gene|SLC7A8,Tamoxifen,,,,,,,,,Activating ERBB2 Mutation,,,Tamoxifen,,,,,"RNA, Messenger","Chemotherapy, Adjuvant",Dissection,,,
,Organ,,,Neoadjuvant Chemotherapy,,Screening procedure,estrogens,Liposarcoma recurrent,,,,,,,,,talazoparib,,,Daughter,,,,,Immunohistochemistry,PIMREG gene|PIMREG,Radiation therapy,,,
,Estrogen Receptors,,,Preoperative Chemotherapy,,Male population group,Antineoplastic Agents,Pituitary macroadenoma,,,,,,,,,Pharmacotherapy,,,Raloxifene,,,,,Immunohistochemistry,Noninfiltrating Intraductal Carcinoma,Excision,,,
,Hormone Receptor,,,Pharmacotherapy,,Vitality,IMPACT gene,Operative Surgical Procedures,,,,,,,,,bevacizumab,,,Patient referral,,,,,Neoplasm,"Receptors, Cytoplasmic",Mica,,,
,Therapeutic procedure,,,"Mastectomy, Subcutaneous",,Carcinoma,Neoadjuvant Therapy,Pharmacotherapy,,,,,,,,,paclitaxel,,,Noninfiltrating Intraductal Carcinoma,,,,,beta catenin,PET/CT scan,Mica,,,
,Tamoxifen,,,Mastectomy,,Blood,Antineoplastic Agents,Woman,,,,,,,,,carboplatin,,,Raloxifene,,,,,Immunohistochemistry,Body tissue,Axilla,,,
,HIGH SENSITIVITY,,,Adjuvant Radiation Therapy,,Kidney Calculi,Hormone Therapy,Radiation therapy,,,,,,,,,bevacizumab,,,Woman,,,,,Malignant neoplasm of breast,Body tissue,Axillary Lymph Node Dissection,,,
,Disease,,,Combination Drug Therapy,,Risk Assessment,Adjuvant Therapy,TP53 gene|TP53,,,,,,,,,Combined Modality Therapy,,,Tamoxifen,,,,,CTNND1|IGSF1|NOP2|RASA1|BRD8|NSUN5,Cerebrovascular accident,Screening mammography,,,
,Woman,,,"Hyperthermia, Local",,Physical function,First line treatment,Malignant neoplasm of breast,,,,,,,,,carboplatin,,,Woman,,,,,Mammary Gland Parenchyma,Breast-Conserving Surgery,Disease,,,
,Aromatase Inhibitors,,,Adjuvant Radiation Therapy,,Woman,Immunologic Adjuvants,Amenorrhea,,,,,,,,,Adverse event,,,Therapeutic procedure,,,,,E-Cadherin,Breast-Conserving Surgery,Pregnancy,,,
,"Radiotherapy, Intensity-Modulated",,,tumor removal,,follow-up,tamoxifen,Malignant neoplasm of breast,,,,,,,,,Carcinoma breast stage IV,,,Immunologic Adjuvants,,,,,Magnetic Resonance Imaging,estrogen receptor-positive breast cancer,fluorodeoxyglucose positron emission tomography,,,
,Cholesterol,,,"Hyperthermia, Local",,Ovarian Carcinoma,Neoadjuvant Therapy,Breast surgery,,,,,,,,,epirubicin,,,Selective Estrogen Receptor Modulators,,,,,pigment epithelium-derived factor,"Receptors, Cytoplasmic",Ultrasonography,,,
,Aromatase Inhibitors,,,"Radiotherapy, Intensity-Modulated",,Diagnosis,IGFBP7|SFPQ,Upper arm,,,,,,,,,cyclophosphamide,,,Placebos,,,,,E-Cadherin,Possible,Axilla,,,
,Breast radiotherapies,,,Neoadjuvant Chemotherapy,,Triple test,BCL2 gene|BCL2,Endocrine therapy,,,,,,,,,olaparib,,,Pharmaceutical Preparations,,,,,Ceramide glucosyltransferase,Tumor Microenvironment,Fine needle aspiration biopsy,,,
,Ovary,,,Neoadjuvant Chemotherapy,,Ovaro-,Hypersensitivity,Malignant neoplasm of breast,,,,,,,,,bevacizumab,,,Malignant neoplasm of breast,,,,,Apolipoprotein A-I|APOA1,Malignant neoplasm of thyroid,Cells,,,
,Radiation therapy,,,Woman,,Alternative Therapies,IMPACT gene,Breast-Conserving Surgery,,,,,,,,,Neoadjuvant Chemotherapy,,,Woman,,,,,Ceramide glucosyltransferase,Endocrine System Diseases,African American,,,
,Tamoxifen,,,Hypofractionated radiation therapy,,Hormone replacement therapy,Aromasin,Malignant neoplasm of breast,,,,,,,,,bevacizumab,,,Elderly,,,,,Body tissue,Tumor Suppressor Genes,Fine needle aspiration biopsy,,,
,Tamoxifen,,,Hypofractionated radiation therapy,,Gamma Cameras,Polysaccharides,Malignant neoplasm of breast,,,,,,,,,carboplatin,,,Tamoxifen,,,,,inhibitors,glycine,Malignant neoplasm of breast,,,
,AR gene|AR,,,Hypofractionated radiation therapy,,Gamma Cameras,Hormone Therapy,Breast surgery,,,,,,,,,paclitaxel,,,Therapeutic procedure,,,,,"Tissue, Paraffin",GJA1 gene|GJA1,Vitamin A,,,
,anastrozole,,,Tomotherapy,,Prevention,Hormone Therapy,Puncture biopsy,,,,,,,,,Cytotoxic Chemotherapy,,,Therapeutic procedure,,,,,Pharmacotherapy,"ORF74 protein, Human herpesvirus 8",Radionuclide Imaging,,,
,BRCA1 gene|BRCA1,,,Neoadjuvant Chemotherapy,,Radiation therapy,palbociclib,Breast-Conserving Surgery,,,,,,,,,Neoadjuvant Therapy,,,Tamoxifen,,,,,Primary Neoplasm,"ORF74 protein, Human herpesvirus 8",Ultrasonography,,,
,Mastectomy,,,Hypofractionated radiation therapy,,Study models,Therapeutic regimen,Ovarian Carcinoma,,,,,,,,,Neoadjuvant Therapy,,,Tamoxifen,,,,,radical mastectomy,Malignant neoplasm of breast,STK11 gene|STK11,,,
,Aromatase Inhibitors,,,Neoadjuvant Chemotherapy,,Mammography,Neoadjuvant Therapy,Body tissue,,,,,,,,,Blindness,,,Woman,,,,,Tissue specimen,"ORF74 protein, Human herpesvirus 8",Fine needle aspiration biopsy,,,
,Mastectomy,,,Neoadjuvant Chemotherapy,,follow-up,fulvestrant,ERBB2|NEU1|NEURL1,,,,,,,,,"herstatin protein, human",,,Clinical Research,,,,,Pharmacotherapy,,Urine protein,,,
,Pulmonary toxicity,,,Chemotherapy Regimen,,Assay,IGFBP7|SFPQ,Malignant neoplasm of breast,,,,,,,,,130-nm albumin-bound paclitaxel,,,Breast cancer metastatic,,,,,Proto-Oncogene Proteins c-jun|JUN,,receptor for advanced glycation endproducts,,,
,Malignant neoplasm of breast,,,PET/CT scan,,Malignant neoplasm of breast,Functional assessment,Mammary Neoplasms,,,,,,,,,erbB-2 Receptor|ERBB2,,,Individual,,,,,Protein p53|TP53,,Immunologic Adjuvants,,,
,Tamoxifen,,,"Radiotherapy, Adjuvant",,Malignant neoplasm of breast,Neoadjuvant Therapy,Malignant neoplasm of breast,,,,,,,,,Positron-Emission Tomography,,,Woman,,,,,Operative Surgical Procedures,,Magnetic Resonance Imaging,,,
,anastrozole,,,Neoadjuvant Chemotherapy,,Cessation of life,Body tissue,Diffuse Scleroderma,,,,,,,,,pembrolizumab,,,Breast cancer metastatic,,,,,ERBB2|NEU1|NEURL1,,Ultrasonography,,,
,Operative Surgical Procedures,,,First line treatment,,Clinic,NF-kappa B,Tamoxifen,,,,,,,,,Neoadjuvant Chemotherapy,,,case control,,,,,tissue processing,,Malignant neoplasm of breast,,,
,Patients,,,Neoadjuvant Chemotherapy,,Early,Magnetic Resonance Imaging,Malignant neoplasm of breast,,,,,,,,,talazoparib,,,celecoxib,,,,,Tissue specimen,,Sentinel Lymph Node Biopsy,,,
,Magnetic Resonance Imaging,,,External Beam Radiation Therapy,,"Leukemia, Myelocytic, Acute",Hormone Therapy,Malignant neoplasm of breast,,,,,,,,,pembrolizumab,,,Raloxifene,,,,,Local excision,,Magnetic Resonance Imaging,,,
,Radiation therapy,,,Neoadjuvant Chemotherapy,,Mammography,PIK3CB wt Allele|PIK3CA|PIK3CB|PIK3CD|PIK3CG,Diethylstilbestrol,,,,,,,,,Chemotherapy Regimen,,,Tamoxifen,,,,,Radiation therapy,,Magnetic Resonance Imaging,,,
,Radiation therapy,,,Paraneoplastic encephalitis,,Operative Surgical Procedures,NF-kappa B,Graves' Disease,,,,,,,,,Hypersensitivity,,,Advanced cancer,,,,,beta catenin,,Sentinel Lymph Node Biopsy,,,
,Malignant neoplasm of breast,,,Patients,,Malignant Neoplasms,DNA,Neoplasm,,,,,,,,,ruxolitinib,,,Risk Assessment,,,,,CTNNB1 Gene Mutation,,Bilateral salpingectomy with oophorectomy,,,
,CHEK2 gene|CHEK2,,,cyclophosphamide,,Core needle biopsy,CARM1 gene|CARM1,ATM gene|ATM,,,,,,,,,130-nm albumin-bound paclitaxel,,,Aromatase Inhibitors,,,,,beta catenin,,Tumor Markers,,,
,CHEK2 gene|CHEK2,,,Mastectomy,,Magnetic Resonance Imaging,Biopsy,Operative Surgical Procedures,,,,,,,,,Neoadjuvant Chemotherapy,,,Ovarian Carcinoma,,,,,arginyl-glycyl-aspartic acid,,Axillary Lymph Node Dissection,,,
,Tamoxifen,,,zoledronic acid,,Woman,IMPACT gene,Patients,,,,,,,,,bevacizumab,,,Chemopreventive Agent,,,,,Cyclin D1|CCND1,,Malignant Neoplasms,,,
,XCL1 gene|XCL1,,,Therapeutic regimen,,Woman,DDX39A,Germ-Line Mutation,,,,,,,,,Hormone Therapy,,,"Drugs, Non-Prescription",,,,,receptor expression,,Dissection,,,
,Tamoxifen,,,Zoledronic acid therapy,,Mammography,Kinome,Lesion,,,,,,,,,eribulin,,,research,,,,,CYCLOPHOSPHAMIDE TREATMENT,,Chest CT,,,
,ATM gene|ATM,,,Patients,,Woman,CXXC5 gene|CXXC5,Fixation of pendulous breast,,,,,,,,,Neoadjuvant Chemotherapy,,,Precancerous lesions,,,,,Body tissue,,IGF1 gene|IGF1,,,
,ERBB2|NEU1|NEURL1,,,Neoadjuvant Chemotherapy,,Genetic screening method,PIK3CB wt Allele|PIK3CA|PIK3CB|PIK3CD|PIK3CG,Operative Surgical Procedures,,,,,,,,,paclitaxel,,,Clinical Research,,,,,Neoplasm Metastasis,,Magnetic Resonance Imaging,,,
,ERBB2|NEU1|NEURL1,,,trastuzumab,,Falls,BCL2 gene|BCL2,Paclitaxel,,,,,,,,,130-nm albumin-bound paclitaxel,,,Malignant neoplasm of breast,,,,,Secondary malignant neoplasm of lymph node,,Biopsy,,,
,ERBB2|NEU1|NEURL1,,,Neoadjuvant Chemotherapy,,Malignant Neoplasms,Breast-Conserving Surgery,Reduction mammaplasty,,,,,,,,,paclitaxel,,,Aromatase Inhibitors,,,,,Secondary malignant neoplasm of lymph node,,gene polymorphism,,,
,Aromatase Inhibitors,,,Neoadjuvant Chemotherapy,,Diagnosis,Hypersensitivity,Operative Surgical Procedures,,,,,,,,,eribulin,,,Procedures,,,,,Tissue specimen,,Ultrasonography,,,
,Magnetic Resonance Imaging,,,fluorouracil,,Mammography,CDK6-associated protein p18,Pharmacotherapy,,,,,,,,,docetaxel,,,Tamoxifen,,,,,Tissue specimen,,Valine,,,
,Tamoxifen,,,Neoadjuvant Chemotherapy,,Machine Learning,IMPACT gene,Congenital Abnormality,,,,,,,,,erbB-2 Receptor|ERBB2,,,Assessment procedure,,,,,Antigen assay,,gene polymorphism,,,
,Tamoxifen,,,Systemic Therapy,,Mammography,estrogens,Operative Surgical Procedures,,,,,,,,,Pharmacotherapy,,,Intervention regimes,,,,,survivin,,Screening mammography,,,
,Population Group,,,erbB-2 Receptor,,HIV Infections,Magnetic Resonance Imaging,Lesion,,,,,,,,,talazoparib,,,Pharmacologic Substance,,,,,survivin,,CD151,,,
,Aromatase Inhibitors,,,cyclophosphamide,,Contrast Media,IGFBP7|SFPQ,Malignant Neoplasms,,,,,,,,,Pharmacotherapy,,,Tamoxifen,,,,,Body tissue,,DBT,,,
,letrozole,,,trastuzumab,,Local Therapy,Kinome,Neoplasm Metastasis,,,,,,,,,Pharmacotherapy,,,Diet,,,,,ERBB2,,Breast,,,
,exemestane,,,Neoadjuvant Chemotherapy,,Malignant neoplasm of breast,cisplatin,Paclitaxel,,,,,,,,,vinorelbine,,,exemestane,,,,,Body tissue,,inhibitors,,,
,anastrozole,,,Operation on breast,,Medical Imaging,cyclin-dependent kinase 6,Entire left thigh,,,,,,,,,bevacizumab,,,Placebos,,,,,Paraffin,,"SLC25A4 protein, human|SLC25A4",,,
,Mastectomy,,,Extraction,,Mammography,letrozole,Malignant neoplasm of breast,,,,,,,,,apatinib,,,"Mastectomy, Subcutaneous",,,,,Cisplatin,,Edema,,,
,Mastectomy,,,erbB-2 Receptor|ERBB2,,"Contraceptives, Oral",Androgen Receptor,Nipples,,,,,,,,,lapatinib,,,Disease,,,,,Breast-Conserving Surgery,,Patients,,,
,"Radiotherapy, Adjuvant",,,Pharmacotherapy,,Supplementation,quercetin,DNA,,,,,,,,,durvalumab,,,Therapeutic Effect,,,,,Noninfiltrating Intraductal Carcinoma,,survivin,,,
,BRCA1 gene|BRCA1,,,trastuzumab,,Spectrum Analysis,bisphenol A,Dermatomyositis,,,,,,,,,Prophylactic treatment,,,Retinoids,,,,,Breast-Conserving Surgery,,survivin,,,
,Malignant neoplasm of breast,,,lapatinib,,Chest,STAT3 gene|STAT3,Esophagectomy,,,,,,,,,Secondary malignant neoplasm of female breast,,,Bilateral mastectomy,,,,,ERBB2 gene|ERBB2,,Albumins,,,
,Estrogen Antagonists,,,Neoadjuvant Chemotherapy,,"Contraceptives, Oral",Disease Progression,Genetic screening method,,,,,,,,,Neoadjuvant Chemotherapy,,,Clinical Research,,,,,Ceramide glucosyltransferase,,MIRN106A gene|MIR106A,,,
,Hormone Receptor,,,Adriamycin,,Hodgkin Disease,Assay,Operative Surgical Procedures,,,,,,,,,Combined Modality Therapy,,,Clinical Research,,,,,Ceramide glucosyltransferase,,Patients,,,
,Inflammatory Breast Carcinoma,,,fluorouracil,,Molecular Probes,RUNX1,Malignant neoplasm of breast,,,,,,,,,paclitaxel,,,"Clinical Trials, Phase III",,,,,Pharmacotherapy,,FOXP3,,,
,Fenretinide,,,Treatment Protocols,,Fluorescence Spectroscopy,Mandibular left second molar abutment,Combined Modality Therapy,,,,,,,,,olaparib,,,Screening procedure,,,,,Pharmacotherapy,,CD8B1 gene|CD8B,,,
,ATM gene|ATM,,,doxorubicin,,Specialty Group,Polysaccharides,Needle biopsy procedure,,,,,,,,,Pharmacotherapy,,,celecoxib,,,,,Regular exercise,,"Chemotherapy, Adjuvant",,,
,Disease,,,lapatinib,,tomography,fulvestrant,Prognostic Factor,,,,,,,,,apatinib,,,Therapeutic procedure,,,,,ADA,,CD8B1 gene|CD8B,,,
,Ethanol,,,Ultrasonography,,Government hospital,Tamoxifen therapy,Breast,,,,,,,,,Genetic screening method,,,BRCA1 Mutation,,,,,Operative Surgical Procedures,,Immunologic Adjuvants,,,
,Neoplasm,,,Neoadjuvant Chemotherapy,,Biopsy,Estrogen Receptor alpha,Malignant Neoplasms,,,,,,,,,Neoadjuvant Chemotherapy,,,Individual,,,,,Breast Diseases,,Cytostatic Agents,,,
,Tamoxifen,,,Neoadjuvant Chemotherapy,,Inflammatory Response,Polysaccharides,Organ,,,,,,,,,Neoadjuvant Chemotherapy,,,Vitamin D,,,,,Mammography,,Autoimmunity,,,
,Alcohol consumption,,,Neoadjuvant Radiotherapy,,Intervention regimes,Adjuvant Therapy,Operative Surgical Procedures,,,,,,,,,Challenge:Type:Point in time:^Patient:Nominal,,,Woman,,,,,Malignant neoplasm of breast,,RANTES|CCL5,,,
,Magnetic Resonance Imaging,,,Neoadjuvant Chemotherapy,,"Diabetes Mellitus, Non-Insulin-Dependent",Current Therapy,Left breast,,,,,,,,,paclitaxel,,,High Risk Populations,,,,,Metric,,Imaging Techniques,,,
,Cigarette Smoking,,,Neoadjuvant Chemotherapy,,Medical Imaging,Secondary Neoplasm,Core needle biopsy,,,,,,,,,Immunologic Adjuvants,,,Aromatase Inhibitors,,,,,Paget's Disease,,Micronutrients,,,
,Mastectomy,,,Post-mastectomy radiotherapy,,Positron-Emission Tomography,tamoxifen,K-ras Oncogene|KRAS,,,,,,,,,Bevacizumab/Paclitaxel,,,Phytoestrogens,,,,,CDKN2A gene|CDKN2A,,Neoplasm,,,
,Maternal history,,,Systemic Therapy,,Mammography,Mandibular left second molar abutment,Ultrasonography,,,,,,,,,docetaxel,,,Selective Estrogen Receptor Modulators,,,,,E-Cadherin,,,,,
,Diphosphonates,,,Neoadjuvant Chemotherapy,,Specialty Group,"RNA, Long Untranslated",Mammography,,,,,,,,,Bevacizumab Regimen,,,Raloxifene,,,,,Tamoxifen,,,,,
,Reproductive History,,,Neoadjuvant Chemotherapy,,tomography,tamoxifen,Neoplasm,,,,,,,,,Neoadjuvant Chemotherapy,,,lapatinib,,,,,SATB1,,,,,
,Woman,,,Neoadjuvant Chemotherapy,,Ultrasonography,Body tissue,Common Neoplasm,,,,,,,,,Neoadjuvant Chemotherapy,,,Chemopreventive Agent,,,,,Patients,,,,,
,Tamoxifen,,,Neoadjuvant Chemotherapy,,Mammography,Aromatase,letrozole,,,,,,,,,Tumor Progression,,,Food,,,,,Ceramide glucosyltransferase,,,,,
,Woman,,,TIGIT gene|TIGIT,,Magnetic Resonance Imaging,Pharmacotherapy,"Radiotherapy, Intensity-Modulated",,,,,,,,,"Chemotherapy, Adjuvant",,,Tamoxifen,,,,,maspin|SERPINB5,,,,,
,4-chlorophenyl methyl sulfide,,,Neoadjuvant Chemotherapy,,Probes,STAT3 gene|STAT3,Therapeutic procedure,,,,,,,,,Neoadjuvant Chemotherapy,,,Woman,,,,,Twist Transcription Factor,,,,,
,Mastectomy,,,Carcinoma breast stage IV,,Malignant neoplasm of breast,Therapeutic procedure,Therapeutic procedure,,,,,,,,,Hormone Therapy,,,exemestane,,,,,Polymerase Chain Reaction,,,,,
,Magnetic Resonance Imaging,,,"lymphocyte-activation gene 3 protein, human",,Cancer Treatment,NR2F1-AS1 gene|NR2F1-AS1,Synchronous Bilateral Breast Carcinoma,,,,,,,,,cyclophosphamide,,,Caloric Restriction,,,,,TWIST1 gene|TWIST1,,,,,
,Mastectomy,,,Mastectomy,,Breast cancer invasive NOS,anastrozole,"Carcinoma, Lobular",,,,,,,,,docetaxel,,,Caloric Restriction,,,,,Breast-Conserving Surgery,,,,,
,Mastectomy,,,Pharmacotherapy,,Mass Fragmentography,tamoxifen,Chromosomal Instability,,,,,,,,,Pharmacotherapy,,,exemestane,,,,,Immunohistochemistry,,,,,
,Magnetic Resonance Imaging,,,BARRIER,,Fine needle aspiration biopsy,LINC00160 gene|LINC00160,Therapeutic procedure,,,,,,,,,AKT1 gene|AKT1,,,Pharmaceutical Preparations,,,,,ezrin,,,,,
,Mastectomy,,,Neoadjuvant Chemotherapy,,Radionuclide Imaging,Cyclin-Dependent Kinase Inhibitor Proteins,Malignant Neoplasms,,,,,,,,,Neoadjuvant Chemotherapy,,,Woman,,,,,ezrin,,,,,
,Tamoxifen,,,Excision of axillary lymph nodes group,,Magnetic Resonance Spectroscopy,"RNA, Long Untranslated",Radiation therapy,,,,,,,,,bevacizumab,,,Dietary Modification,,,,,E-Cadherin,,,,,
,Ovariectomy,,,BARRIER,,Toxic effect,Immunologic Adjuvants,Mastectomy,,,,,,,,,Pharmacotherapy,,,Diphosphonates,,,,,E-Cadherin,,,,,
,"Anti-Inflammatory Agents, Non-Steroidal",,,"Receptors, Immunologic",,Biosensors,letrozole,Excision,,,,,,,,,lapatinib,,,Intervention regimes,,,,,Cadherins,,,,,
,Non-Aspirin,,,Mucin-1 Antigen,,Academic Medical Centers,Malignant neoplasm of breast,Bilateral mastectomy,,,,,,,,,Pharmacotherapy,,,Woman,,,,,Neoplasm,,,,,
,Tamoxifen,,,HAVCR2 gene|HAVCR2,,Malignant neoplasm of breast,Hormone Therapy,Radiation therapy,,,,,,,,,epirubicin,,,Woman,,,,,Immunohistochemistry,,,,,
,Tamoxifen,,,Granulocyte Colony-Stimulating Factor|CSF2|LAMC2,,"Diabetes Mellitus, Non-Insulin-Dependent",Neoadjuvant Therapy,Biopsy,,,,,,,,,bendamustine,,,Population Group,,,,,Carcinogenesis,,,,,
,Tamoxifen,,,HAVCR2 gene|HAVCR2,,Excision,Genes,Operative Surgical Procedures,,,,,,,,,eribulin,,,epigallocatechin gallate,,,,,Noninfiltrating Intraductal Carcinoma,,,,,
,Compete,,,Body tissue,,Study models,Neoadjuvant Therapy,Axillary Lymph Node Dissection,,,,,,,,,Neoadjuvant Therapy,,,Treatment Protocols,,,,,"Tomography, Emission-Computed",,,,,
,Malignant neoplasm of breast,,,TIGIT gene|TIGIT,,Immunohistochemistry,MIR143 gene|MIR143,Pharmacotherapy,,,,,,,,,capecitabine,,,Raloxifene,,,,,Operative Surgical Procedures,,,,,
,Woman,,,"lymphocyte-activation gene 3 protein, human",,"Diagnosis, Computer-Assisted",tamoxifen,BRCA1 gene|BRCA1,,,,,,,,,paclitaxel,,,research,,,,,"Tomography, Emission-Computed",,,,,
,Radiation therapy,,,Neoadjuvant Chemotherapy,,Therapeutic procedure,Estrogen Receptor alpha,Pharmacotherapy,,,,,,,,,Pharmacotherapy,,,Raloxifene,,,,,Metric,,,,,
,Fenretinide,,,Parametric Image,,Functional Imaging,"RNA, Messenger",Pharmacotherapy,,,,,,,,,bevacizumab,,,Tamoxifen,,,,,Breast cancer invasive NOS,,,,,
,Patients,,,Transarterial Chemoembolization,,Malignant neoplasm of breast,tamoxifen,BRCA1 Mutation,,,,,,,,,AKT Inhibitor,,,Ovariectomy,,,,,Breast cancer invasive NOS,,,,,
,Therapeutic procedure,,,Non-Steroidal Aromatase Inhibitor,,adjuvant therapy,Neoadjuvant Therapy,CHEK2 gene|CHEK2,,,,,,,,,Pharmacotherapy,,,Tamoxifen,,,,,Hormone Receptor,,,,,
,Patients,,,Responsive Disease,,Diagnosis,Therapeutic procedure,PALB2,,,,,,,,,Pharmacotherapy,,,Menopausal symptom,,,,,Mucinous breast cancer,,,,,
,Tamoxifen,,,Neoadjuvant Chemotherapy,,Carrier of disorder,inhibitors,bevacizumab,,,,,,,,,Pharmacotherapy,,,Population Group,,,,,Hormone Receptor,,,,,
,"Blood Count, Complete",,,Neoadjuvant Chemotherapy,,Energy Balance,tamoxifen,TP53 gene|TP53,,,,,,,,,eribulin,,,Woman,,,,,Malignant neoplasm of breast,,,,,
,Patients,,,Neoadjuvant Chemotherapy,,Woman,tamoxifen,Patients,,,,,,,,,Pharmacotherapy,,,Tamoxifen,,,,,Mammary Gland Parenchyma,,,,,
,Woman,,,letrozole,,Supplementation,Recurrent tumor,Female Breast Carcinoma,,,,,,,,,paclitaxel,,,Vaccines,,,,,Noninfiltrating Intraductal Carcinoma,,,,,
,Disease,,,exemestane,,Antisense RNA,tamoxifen,Breast,,,,,,,,,Neoadjuvant Chemotherapy,,,Woman,,,,,Noninfiltrating Intraductal Carcinoma,,,,,
,Tamoxifen,,,Neoadjuvant Chemotherapy,,"Diagnosis, Computer-Assisted",Neoadjuvant Therapy,CFC1 gene|CFC1,,,,,,,,,Neoadjuvant Chemotherapy,,,Selective Estrogen Receptor Modulators,,,,,DNA,,,,,
,Malignant neoplasm of breast,,,Operative Surgical Procedures,,Diagnosis,Pharmacotherapy,comparative genomic analysis,,,,,,,,,sunitinib,,,"Clinical Trials, Phase III",,,,,Noninfiltrating Intraductal Carcinoma,,,,,
,Patients,,,PET/CT scan,,Ovarian Stimulation,Pharmacotherapy,Keloid,,,,,,,,,Combination Drug Therapy,,,advanced disease,,,,,Breast Cancer Model,,,,,
,Mastectomy,,,Combined Modality Therapy,,Contrast Media,tamoxifen,Operative Surgical Procedures,,,,,,,,,paclitaxel,,,dietary intervention,,,,,,,,,,
,Tamoxifen,,,neoplasm regression,,Health System,inhibitors,Ovaro-,,,,,,,,,fulvestrant,,,Carrier of disorder,,,,,,,,,,
,Pharmacotherapy,,,Systemic Therapy,,Image Processing,"4-hydroxy-N-desmethyltamoxifen, (Z)-isomer",Radiation therapy,,,,,,,,,Pharmacotherapy,,,Clinical Research,,,,,,,,,,
,adjuvant therapy,,,Hypofractionated radiation therapy,,Therapeutic procedure,Hormone Therapy,Infiltrating duct carcinoma,,,,,,,,,HER2-positive carcinoma of breast,,,Malignant Neoplasms,,,,,,,,,,
,Radiation therapy,,,Hypofractionated radiation therapy,,radiologist,Recurrent tumor,Malignant neoplasm of breast,,,,,,,,,MKI67 gene|MKI67,,,Neoplasm,,,,,,,,,,
,Therapeutic procedure,,,Neoadjuvant Chemotherapy,,Medical Imaging,Estrogen Antagonists,Population Group,,,,,,,,,Neoadjuvant Chemotherapy,,,Cathepsins B,,,,,,,,,,
,Asians,,,Neoadjuvant Chemotherapy,,Malignant neoplasm of breast,MKI67 gene|MKI67,Pharmacotherapy,,,,,,,,,Treatment Protocols,,,Estrogen Antagonists,,,,,,,,,,
,Population Group,,,Mammaplasty,,breast implant procedure,Malignant neoplasm of breast,Combined Modality Therapy,,,,,,,,,Inhibitor,,,Woman,,,,,,,,,,
,Upper arm,,,Hypofractionated radiation therapy,,Ultrasonography,letrozole,Breast,,,,,,,,,palbociclib,,,adjuvant therapy,,,,,,,,,,
,Pharmacotherapy,,,"herstatin protein, human",,Aggressive behavior,ribociclib,Progestins,,,,,,,,,Pharmacotherapy,,,Woman,,,,,,,,,,
,Pharmacotherapy,,,Pharmacotherapy,,Specialty Group,Pharmacotherapy,Boards,,,,,,,,,taxane,,,Gonadotropin-Releasing Hormone Analog,,,,,,,,,,
,Tamoxifen,,,post surgery radiation therapy,,Digital mammography,Pharmacotherapy,Estrogens,,,,,,,,,opium alkaloids and derivative combination cough suppressants,,,Carcinogenicity,,,,,,,,,,
,Breast cancer invasive NOS,,,Volumetric-Modulated Arc Therapy,,Cessation of life,Organoids,Radiation therapy,,,,,,,,,Immunologic Adjuvants,,,research,,,,,,,,,,
,Magnetic Resonance Imaging,,,Hypofractionated radiation therapy,,Fine needle aspiration biopsy,Pharmacotherapy,Neoplasm,,,,,,,,,Pharmacotherapy,,,Woman,,,,,,,,,,
,Woman,,,Conventional Treatment,,Excision biopsy,Hormone Therapy,Malignant neoplasm of breast,,,,,,,,,inhibitors,,,Estrogen Antagonists,,,,,,,,,,
,Malignant Neoplasms,,,PDCD1 gene|PDCD1,,Diagnostic radiologic examination,Pharmacotherapy,Therapeutic procedure,,,,,,,,,Histone deacetylase inhibitor|HDAC9,,,"Fatty Acids, Omega-3",,,,,,,,,,
,Tamoxifen,,,Neoadjuvant Chemotherapy,,Bone Density,"AGR3 protein, human|AGR3",Drainage procedure,,,,,,,,,Patients,,,Soy Milk,,,,,,,,,,
,Mammography,,,Pharmacotherapy,,Malignant Neoplasms,Neoadjuvant Therapy,Radiation therapy,,,,,,,,,HER2-positive carcinoma of breast,,,Woman,,,,,,,,,,
,Woman,,,Neoadjuvant Chemotherapy,,Estrogen Replacement Therapy,Pharmaceutical Preparations,TP53 gene|TP53,,,,,,,,,Phosphatidylinositide 3-Kinase Inhibitor,,,Malignant neoplasm of breast,,,,,,,,,,
,Patients,,,post surgery radiation therapy,,Patients,arctigenin,ERBB2 gene|ERBB2,,,,,,,,,First line treatment,,,Human Chorionic Gonadotropin,,,,,,,,,,
,Mammography,,,Antibodies,,Neoplasm,Systemic Therapy,Radiation therapy,,,,,,,,,AKT Inhibitor,,,Selective Estrogen Receptor Modulators,,,,,,,,,,
,Mammography,,,doxorubicin,,Lesion,Hormone Therapy,Malignant neoplasm of breast,,,,,,,,,Hypersensitivity,,,Human,,,,,,,,,,
,Mammography,,,cyclophosphamide,,Lesion,Biological Response Modifiers,Disease,,,,,,,,,Patients,,,Therapeutic procedure,,,,,,,,,,
,Therapeutic procedure,,,Patients,,Menopause,letrozole,Hodgkin Disease,,,,,,,,,Copy Number Polymorphism,,,Estrogen Antagonists,,,,,,,,,,
,Woman,,,130-nm albumin-bound paclitaxel,,Therapeutic procedure,Genome,Mastectomy,,,,,,,,,Oncologists,,,Treatment Protocols,,,,,,,,,,
,Mammography,,,atezolizumab,,Immunologic Adjuvants,Pharmacotherapy,Therapeutic procedure,,,,,,,,,Oncologists,,,research,,,,,,,,,,
,Malignant neoplasm of breast,,,Neoadjuvant Chemotherapy,,Carrier of disorder,Pharmacotherapy,ERBB2 gene|ERBB2,,,,,,,,,talazoparib,,,Woman,,,,,,,,,,
,Mammography,,,Neoadjuvant Chemotherapy,,Mastectomy,Transcript,Therapeutic procedure,,,,,,,,,IMPACT gene,,,Estrogen Antagonists,,,,,,,,,,
,Tamoxifen,,,Parametric Image,,Medical Surveillance,Hormone Therapy,Radiation therapy,,,,,,,,,Hypersensitivity,,,Docosahexaenoic Acids,,,,,,,,,,
,Tamoxifen,,,Volumetric-Modulated Arc Therapy,,Triple test,COX5A gene|COX5A,Therapeutic procedure,,,,,,,,,paclitaxel,,,Endocrine therapy,,,,,,,,,,
,Tamoxifen,,,Curative Surgery,,Introduction procedure,AGR2,Therapeutic procedure,,,,,,,,,apatinib,,,"Fatty Acids, Omega-3",,,,,,,,,,
,Body mass index,,,BECN1 gene|BECN1,,Microelectrodes,Hormone Therapy,Lymphoma,,,,,,,,,apatinib,,,Disease,,,,,,,,,,
,exemestane,,,Neoadjuvant Therapy,,Woman,Pharmaceutical Preparations,Mutation,,,,,,,,,Neoadjuvant Chemotherapy,,,Human,,,,,,,,,,
,bilateral breast cancer,,,TAC Regimen,,Malignant neoplasm of breast,tamoxifen,"Contraceptives, Oral",,,,,,,,,paclitaxel,,,Raloxifene,,,,,,,,,,
,Steroidal Aromatase Inhibitor,,,Neoadjuvant Chemotherapy,,Pharmacotherapy,Therapeutic procedure,Duct (organ) structure,,,,,,,,,trastuzumab deruxtecan,,,research,,,,,,,,,,
,tomography,,,Neoadjuvant Therapy,,Breast,Body tissue,Individual,,,,,,,,,talazoparib,,,Tamoxifen,,,,,,,,,,
,Malignant neoplasm of breast,,,Beclin-1,,Personal Satisfaction,Neoadjuvant Therapy,"Radiotherapy, Intensity-Modulated",,,,,,,,,bevacizumab,,,deguelin,,,,,,,,,,
,Malignant neoplasm of breast,,,pyrotinib,,Diagnosis,Pharmacotherapy,Therapeutic procedure,,,,,,,,,Pharmacotherapy,,,Woman,,,,,,,,,,
,Estrogen Receptor Status,,,Diagnosis,,Study models,MMP10 gene|MMP10,Malignant neoplasm of breast,,,,,,,,,Second line treatment,,,Malignant neoplasm of breast,,,,,,,,,,
,Ovariectomy,,,Sentinel Lymph Node Biopsy,,Malignant neoplasm of breast,Pharmacotherapy,Malignant neoplasm of breast,,,,,,,,,cabazitaxel,,,Tamoxifen,,,,,,,,,,
,Patients,,,Canine Soft Tissue Sarcoma,,Disease,Pharmacotherapy,Chromosome abnormality,,,,,,,,,nivolumab,,,Group education,,,,,,,,,,
,Ovarian Carcinoma,,,Neoadjuvant Chemotherapy,,Therapeutic procedure,"AGR3 protein, human|AGR3",Mammography,,,,,,,,,cabazitaxel,,,Therapeutic procedure,,,,,,,,,,
,BRCA1 gene|BRCA1,,,Neoadjuvant Chemotherapy,,Magnetic Resonance Imaging,Body tissue,Therapeutic procedure,,,,,,,,,Pharmacotherapy,,,Patients,,,,,,,,,,
,Malignant neoplasm of breast,,,Neoadjuvant Chemotherapy,,Diagnosis,EC Breast Regimen,"Chemotherapy, Adjuvant",,,,,,,,,paclitaxel,,,Tamoxifen,,,,,,,,,,
,Magnetic Resonance Imaging,,,Neoadjuvant Therapy,,Diagnosis,SPAG5 gene|SPAG5,CISH,,,,,,,,,Poly(ADP-ribose) Polymerases,,,Woman,,,,,,,,,,
,Family,,,Neoadjuvant Chemotherapy,,Screening mammography,Immunologic Adjuvants,PTEN Phosphohydrolase|PTEN,,,,,,,,,Neoadjuvant Chemotherapy,,,Tamoxifen,,,,,,,,,,
,BRCA2 gene|BRCA2,,,Neoadjuvant Chemotherapy,,Therapeutic procedure,Late Relapse,ATM gene|ATM,,,,,,,,,fulvestrant,,,Tamoxifen,,,,,,,,,,
,Patients,,,Physical function,,"Diagnosis, Computer-Assisted",CDK4/6 Inhibition,Malignant neoplasm of breast,,,,,,,,,N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide,,,Tamoxifen,,,,,,,,,,
,Computer Aided Detection Systems,,,Neoadjuvant Chemoradiotherapy,,Therapeutic procedure,C17orf49 gene|C17orf49,Endocrine therapy,,,,,,,,,Neoadjuvant Chemotherapy,,,Assessment procedure,,,,,,,,,,
,Mammography,,,Frailty,,"Radiotherapy, Adjuvant",Tumor size,Contralateral breast cancer,,,,,,,,,gemcitabine,,,Tamoxifen Citrate,,,,,,,,,,
,Malignant neoplasm of breast,,,Hypofractionated radiation therapy,,Radiation therapy,Tumor Progression,radical mastectomy,,,,,,,,,Toxic effect,,,Tamoxifen,,,,,,,,,,
,Mammography,,,Neoadjuvant Chemotherapy,,"Chemotherapy, Adjuvant",Elastoid degeneration,Woman,,,,,,,,,palbociclib,,,Woman,,,,,,,,,,
,Mastectomy,,,Neoadjuvant Chemotherapy,,Biopsy,tamoxifen,trastuzumab,,,,,,,,,Ganetespib,,,Woman,,,,,,,,,,
,Mammography,,,Mammaplasty,,Diagnosis,Neoplasms,Mastectomy,,,,,,,,,Ultrasonography,,,Malignant neoplasm of breast,,,,,,,,,,
,Malignant Neoplasms,,,Toxic effect,,Cancer Center,Selective Estrogen Receptor Down Regulator,Excision,,,,,,,,,letrozole,,,Tamoxifen,,,,,,,,,,
,Woman,,,Hypofractionated radiation therapy,,Diagnosis,tamoxifen,Pharmacotherapy,,,,,,,,,Antibody-Drug Conjugates,,,Raloxifene,,,,,,,,,,
,Malignant neoplasm of breast,,,Mastectomy,,Woman,tamoxifen,Cardiomyopathies,,,,,,,,,"CD69 protein, human|CD69",,,Tamoxifen,,,,,,,,,,
,Therapeutic procedure,,,Genetic Profile,,Microcalcification,tamoxifen,Woman,,,,,,,,,Pharmacotherapy,,,"Diet, Fat-Restricted",,,,,,,,,,
,Patients,,,Excision of axillary lymph nodes group,,Microcalcification,Pharmacotherapy,Doxorubicin,,,,,,,,,pembrolizumab,,,Woman,,,,,,,,,,
,checkpoint kinase 2,,,Assay,,Assessment procedure,tamoxifen,Neoplasm,,,,,,,,,Aromatase Inhibitors,,,Health education,,,,,,,,,,
,Magnetic Resonance Imaging,,,Mammaplasty,,Intervention regimes,Hormone Therapy,Neoplasm,,,,,,,,,Anthracycline Antibiotics,,,Tamoxifen,,,,,,,,,,
,BRCA1 gene|BRCA1,,,Neoadjuvant Chemoradiotherapy,,Daily,Neoadjuvant Therapy,Klinefelter's Syndrome,,,,,,,,,IMPACT gene,,,Tamoxifen,,,,,,,,,,
,Hormone Receptor,,,Mastectomy,,Intervention regimes,fatostatin,Malignant neoplasm of breast,,,,,,,,,IMPACT gene,,,Tamoxifen,,,,,,,,,,
,Mastectomy,,,Neoadjuvant Chemotherapy,,Breast Feeding,Hyperlipidemia,Malignant neoplasm of breast,,,,,,,,,erbB-2 Receptor|ERBB2,,,Clinical Research,,,,,,,,,,
,ERBB2 gene|ERBB2,,,Responsive Disease,,Therapeutic procedure,fatostatin,Malignant neoplasm of breast,,,,,,,,,Bevacizumab/Paclitaxel,,,celecoxib,,,,,,,,,,
,adjuvant therapy,,,Tumor Markers,,Specialty Group,trastuzumab,Malignant Neoplasms,,,,,,,,,fluorouracil,,,educational intervention,,,,,,,,,,
,Tamoxifen,,,Neoadjuvant Chemoradiotherapy,,Gadopentetate Dimeglumine,Pharmacotherapy,Malignant neoplasm of breast,,,,,,,,,palbociclib,,,Clinical Research,,,,,,,,,,
,Hormone Receptor,,,Immunologic Adjuvants,,Diagnosis,Hormone Therapy,Papillary serous cystadenocarcinoma,,,,,,,,,paclitaxel,,,Intervention regimes,,,,,,,,,,
,Tamoxifen,,,Responsive Disease,,Woman,Hypersensitivity,Vimentin,,,,,,,,,Responsiveness assessment,,,Malignant neoplasm of breast,,,,,,,,,,
,Malignant neoplasm of breast,,,Operation on breast,,Woman,Therapeutic procedure,Neoplasm,,,,,,,,,Biological Markers,,,intervention program,,,,,,,,,,
,Mastectomy,,,Mammaplasty,,Intervention regimes,Hormone Therapy,"Muscular Dystrophy, Facioscapulohumeral",,,,,,,,,Agent,,,Health Services,,,,,,,,,,
,Bilateral mastectomy,,,Neoadjuvant Chemotherapy,,Spectrum Analysis,Aromatase Inhibitors,Estrogen Receptors,,,,,,,,,IMPACT gene,,,Patients,,,,,,,,,,
,Magnetic Resonance Imaging,,,PET/CT scan,,Malignant neoplasm of breast,palbociclib,Preventive surgery,,,,,,,,,chlorodihydroxypyridine/potassium oxonate/tegafur,,,Health Services,,,,,,,,,,
,Mastectomy,,,Magnetic resonance imaging of breast,,Exploration procedure,Adjuvant Radiation Therapy,Ovarian Carcinoma,,,,,,,,,epirubicin,,,Health Services,,,,,,,,,,
,Noninfiltrating Intraductal Carcinoma,,,Neoadjuvant Therapy,,Diagnostic Imaging,Adjuvant Therapy,"Polymorphism, Genetic",,,,,,,,,Pharmacotherapy,,,adjuvant therapy,,,,,,,,,,
,Magnetic Resonance Imaging,,,Neoadjuvant Chemotherapy,,Intervention regimes,MZB1 gene|MZB1,Carcinoma,,,,,,,,,BRIP1 gene|BRIP1,,,anastrozole,,,,,,,,,,
,Reduction mammaplasty,,,Neoadjuvant Chemotherapy,,Diagnosis,tamoxifen,Neoplasm,,,,,,,,,cyclophosphamide,,,research,,,,,,,,,,
,Tamoxifen,,,trastuzumab,,Prevention,Neoadjuvant Therapy,Squamous cell carcinoma,,,,,,,,,ribociclib,,,Noninfiltrating Intraductal Carcinoma,,,,,,,,,,
,Obesity,,,Neoadjuvant Therapy,,Procedures,New medications,Treatment Guidelines,,,,,,,,,Single Agent Therapy,,,"Vaccines, DNA",,,,,,,,,,
,Ultrasonography,,,Pharmacotherapy,,Biopsy,"PIK3CA protein, human|PIK3CA",Breast-Conserving Surgery,,,,,,,,,Pharmacotherapy,,,Clinical Research,,,,,,,,,,
,Mammography,,,Neoadjuvant Chemotherapy,,Tissue Fixation,antagonists,Neoplasm,,,,,,,,,Neoadjuvant Therapy,,,AR gene|AR,,,,,,,,,,
,Mammography,,,Programmed cell death ligand 1,,Psychosocial care,Hormone Therapy,BRCA1 gene|BRCA1,,,,,,,,,eribulin,,,Population Group,,,,,,,,,,
,Woman,,,Treatment Protocols,,month,tamoxifen,Malignant neoplasm of breast,,,,,,,,,Chemotherapy Regimen,,,Breast cancer invasive NOS,,,,,,,,,,
,Mammography,,,Neoadjuvant Therapy,,Balanced diet,MZB1 gene|MZB1,Radiation therapy,,,,,,,,,bevacizumab,,,Intervention regimes,,,,,,,,,,
,Malignant neoplasm of breast,,,Treatment Protocols,,Psychosocial care,Female Breast Carcinoma,"Radiotherapy, Adjuvant",,,,,,,,,eribulin,,,Mastectomy,,,,,,,,,,
,Patients,,,Programmed cell death ligand 1,,follow-up,tamoxifen,Multimodal Imaging,,,,,,,,,ribociclib,,,Woman,,,,,,,,,,
,Malignant neoplasm of breast,,,pyrotinib,,Secondary malignant neoplasm of bone,Hormone Therapy,Radiation therapy,,,,,,,,,Macrophage Activation,,,Tamoxifen,,,,,,,,,,
,Pharmaceutical Preparations,,,Diffusion weighted imaging,,Operative Surgical Procedures,Systemic Therapy,Therapeutic procedure,,,,,,,,,Pharmacotherapy,,,Raloxifene,,,,,,,,,,
,Malignant neoplasm of breast,,,Neoadjuvant Chemotherapy,,Woman,Hormone Therapy,CDKN2A gene|CDKN2A,,,,,,,,,Pharmacotherapy,,,Woman,,,,,,,,,,
,Malignant Neoplasms,,,Neoadjuvant Chemotherapy,,"Hospitals, General",Hypersensitivity,Radiation therapy,,,,,,,,,palbociclib,,,Woman,,,,,,,,,,
,Mastectomy,,,Pathologic Response,,Malignant neoplasm of breast,Breast-Conserving Surgery,Pharmacotherapy,,,,,,,,,Treatment Protocols,,,Pharmaceutical Preparations,,,,,,,,,,
,Magnetic Resonance Imaging,,,"CD69 protein, human|CD69",,Operative Surgical Procedures,Indazoles,Therapeutic procedure,,,,,,,,,pyrotinib,,,Melatonin,,,,,,,,,,
,Carrier of disorder,,,Neoadjuvant Chemotherapy,,"Spectrum Analysis, Mass",Obesity,Carcinoma,,,,,,,,,sacituzumab govitecan,,,exemestane,,,,,,,,,,
,Radiation,,,Neoadjuvant Chemotherapy,,Mammaplasty,Pharmacotherapy,CDKN1A|TCEAL1|NSG1|H3F3AP6,,,,,,,,,Neoadjuvant Chemotherapy,,,exemestane,,,,,,,,,,
,Hereditary Malignant Neoplasm,,,Curative Surgery,,Therapeutic procedure,Elastoid degeneration,"Radiotherapy, Adjuvant",,,,,,,,,Exosomes,,,Tamoxifen,,,,,,,,,,
,BRCA1 gene|BRCA1,,,Neoadjuvant Therapy,,"Chemotherapy, Adjuvant",Triple Negative Breast Neoplasms,Radiation therapy,,,,,,,,,Poly(ADP-ribose) Polymerase Inhibitors,,,Malignant neoplasm of breast,,,,,,,,,,
,Tamoxifen,,,Mammaplasty,,Therapeutic procedure,estrogen receptor-negative breast cancer,Radiation therapy,,,,,,,,,Pharmacotherapy,,,Woman,,,,,,,,,,
,Patients,,,PET/CT scan,,trastuzumab,Biological Response Modifiers,Mammography,,,,,,,,,Poly(ADP-ribose) Polymerase Inhibitors,,,Tamoxifen,,,,,,,,,,
,CCL27 gene|CCL27,,,Neoadjuvant Chemotherapy,,Woman,Pharmacotherapy,Malignant neoplasm of breast,,,,,,,,,ado-trastuzumab emtansine|DMPK|IGHD1-7,,,Fenretinide,,,,,,,,,,
,Membrane Transport Proteins,,,TP53 gene|TP53,,Fine needle aspiration biopsy,Retinoid X Receptor gamma,Ultrasonography,,,,,,,,,capecitabine,,,Evaluating interventions,,,,,,,,,,
,Mammographic breast density,,,PET/CT scan,,Malignant neoplasm of breast,Malignant Neoplasms,Malignant Neoplasms,,,,,,,,,Pharmacotherapy,,,Nutraceutical,,,,,,,,,,
,Detection,,,Neoadjuvant Chemotherapy,,Malignant neoplasm of breast,Selective Estrogen Receptor Modulators,Malignant neoplasm of breast,,,,,,,,,Luteinizing Hormone-releasing Hormone Agonist,,,Woman,,,,,,,,,,
,Clinical Research,,,Neoadjuvant Chemotherapy,,Disease recurrence,ITGA8 gene|ITGA8,BRCA1 gene|BRCA1,,,,,,,,,Treatment Protocols,,,Woman,,,,,,,,,,
,BRCA2 gene|BRCA2,,,Neoadjuvant Radiotherapy,,Females,Body tissue,Malignant neoplasm of stomach,,,,,,,,,tamoxifen,,,Therapeutic procedure,,,,,,,,,,
,Carrier of disorder,,,Neoadjuvant Chemotherapy,,Specialty Group,Hypersensitivity,Esophagus,,,,,,,,,Cohort,,,Pharmaceutical Preparations,,,,,,,,,,
,Mastectomy,,,Mucin-1 Antigen,,Specialty Group,"RNA, Long Untranslated",Mastectomy,,,,,,,,,vinorelbine,,,Woman,,,,,,,,,,
,Selective Estrogen Receptor Modulators,,,Immunologic Adjuvants,,Malignant neoplasm of breast,ITGA8 gene|ITGA8,Mastectomy,,,,,,,,,apatinib,,,Woman,,,,,,,,,,
,letrozole,,,"HIF1A protein, human|HIF1A",,Surgical biopsy,First line treatment,Radiotherapy planning,,,,,,,,,Pharmacotherapy,,,Woman,,,,,,,,,,
,Mammography,,,Neoadjuvant Chemotherapy,,Mental disorders,Hormone Therapy,Advance,,,,,,,,,palbociclib,,,Aspirin,,,,,,,,,,
,Upper Extremity,,,Operative Surgical Procedures,,Assay,Estrogen Receptors,Noninfiltrating Intraductal Carcinoma,,,,,,,,,durvalumab,,,Woman,,,,,,,,,,
,Tamoxifen,,,Hypofractionated radiation therapy,,"Risk factor, cardiovascular",tamoxifen,Radiation therapy,,,,,,,,,Breast-Conserving Surgery,,,Selective Estrogen Receptor Modulators,,,,,,,,,,
,Tamoxifen,,,FDG-Positron Emission Tomography and Computed Tomography Scan,,E-Cadherin|EREG|ESR1,Selective Estrogen Receptor Modulators,Radiation therapy,,,,,,,,,Oncolytic Virotherapy,,,Non-infiltrating lobular carcinoma,,,,,,,,,,
,Tamoxifen,,,"Chemotherapy, Adjuvant",,Therapeutic procedure,XBP1 gene|XBP1,Mammaplasty,,,,,,,,,Immune,,,Tamoxifen,,,,,,,,,,
,Mastectomy,,,Immunologic Adjuvants,,ERBB2|NEU1|NEURL1,Estrogen Receptor alpha,Mammography,,,,,,,,,Signal Transduction,,,Tamoxifen,,,,,,,,,,
,Reduction - action,,,systemic administration,,Woman,Oncogenes,Mammography,,,,,,,,,DNA Repair,,,Tamoxifen,,,,,,,,,,
,Alleles,,,Neoadjuvant Chemotherapy,,Malignant neoplasm of breast,Hormone Therapy,Second Primary Cancers,,,,,,,,,nivolumab,,,Intervention regimes,,,,,,,,,,
,Not significant,,,Treatment Protocols,,Metric,Estrogen Receptor Inhibitor [EPC],Operative Surgical Procedures,,,,,,,,,IMPACT gene,,,Woman,,,,,,,,,,
,Alleles,,,Active Breathing Coordinator-Mediated Radiation Therapy,,Focus Groups,Body tissue,Operative Surgical Procedures,,,,,,,,,Second line treatment,,,Tamoxifen,,,,,,,,,,
,Single Nucleotide Polymorphism,,,cyclophosphamide,,Malignant neoplasm of breast,MicroRNA 205-5p,"Radiotherapy, Adjuvant",,,,,,,,,BARRIER,,,Selective Estrogen Receptor Modulators,,,,,,,,,,
,Single Nucleotide Polymorphism,,,vinorelbine,,Hormone Receptor,tamoxifen,Implantable venous access port,,,,,,,,,Immunologic Adjuvants,,,Clinical Research,,,,,,,,,,
,Single Nucleotide Polymorphism,,,Mastectomy,,Intervention regimes,PRR11 gene|PRR11,Therapeutic procedure,,,,,,,,,Hormone Therapy,,,Human,,,,,,,,,,
,Patients,,,anaphylaxis,,Procedures,Bombesin Receptor,Malignant Neoplasms,,,,,,,,,eribulin,,,Tamoxifen,,,,,,,,,,
,Single Nucleotide Polymorphism,,,Acute hemorrhage,,Breast Self-Examination,tumor growth,Malignant neoplasm of breast,,,,,,,,,ribociclib,,,Tamoxifen,,,,,,,,,,
,Tamoxifen,,,trastuzumab,,BASELINE,Oncogenes,Medullary,,,,,,,,,"CDKN2C protein, human|CDKN2C",,,Tamoxifen,,,,,,,,,,
,Tamoxifen,,,Neoadjuvant Chemotherapy,,Diagnosis,Estrogen Receptor alpha,Bilateral Malignant Neoplasm,,,,,,,,,ipilimumab,,,Fenretinide,,,,,,,,,,
,Pharmacotherapy,,,Mammaplasty,,Mammography,Targeted Therapy,Malignant neoplasm of breast,,,,,,,,,olaparib,,,Woman,,,,,,,,,,
,Tamoxifen,,,fluorouracil,,Prostate,trastuzumab,Malignant neoplasm of breast,,,,,,,,,eribulin,,,Woman,,,,,,,,,,
,Mammography,,,Desensitization,,Disease,"MLL3 protein, human|KMT2C",Imaging Techniques,,,,,,,,,taxane,,,Woman,,,,,,,,,,
,Patients,,,Neoadjuvant Chemotherapy,,Study models,Estrogen Receptors,Mastectomy,,,,,,,,,trastuzumab deruxtecan,,,Tamoxifen,,,,,,,,,,
,Hormone Receptor,,,Hormone Therapy,,cohort,Estrogen Receptor Inhibitor [EPC],BRCA1 gene|BRCA1,,,,,,,,,Hormone Therapy,,,Tamoxifen,,,,,,,,,,
,Ovarian Carcinoma,,,pyrotinib,,Neoplasm,First line treatment,BRCA2 gene|BRCA2,,,,,,,,,doxorubicin liposome,,,Woman,,,,,,,,,,
,Therapeutic procedure,,,Neoadjuvant Therapy,,Mammography,"TFF1 protein, human|TFF1",Malignant neoplasm of breast,,,,,,,,,RNF5 gene|RNF5,,,exemestane,,,,,,,,,,
,Tamoxifen,,,Single Agent Therapy,,Tissue specimen,Oncogenes,"Carcinoma, Ductal, Breast",,,,,,,,,Angiogenesis Inhibitors,,,"Clinical Trials, Phase II",,,,,,,,,,
,Radiation therapy,,,simvastatin,,"Diagnosis, Computer-Assisted",Neoplasm Metastasis,Tamoxifen,,,,,,,,,eribulin,,,Raloxifene,,,,,,,,,,
,Estrogen Receptor Status,,,Reconstructive Surgical Procedures,,Diagnosis,USP11 gene|USP11,Bilateral mastectomy,,,,,,,,,nivolumab,,,Tamoxifen,,,,,,,,,,
,Tamoxifen,,,trastuzumab,,Reconstructive Surgical Procedures,Pharmacotherapy,Pulmonary toxicity,,,,,,,,,Excision of axillary lymph nodes group,,,Tamoxifen,,,,,,,,,,
,Therapeutic procedure,,,vinorelbine,,Phage Display,Hormone Therapy,"Radiotherapy, Adjuvant",,,,,,,,,Targeted Therapy,,,Intervention regimes,,,,,,,,,,
,Hormone Receptor,,,ado-trastuzumab emtansine,,psychological distress,CYP27A1 gene|CYP27A1,Radiation therapy,,,,,,,,,Targeted Therapy Agent,,,Tamoxifen,,,,,,,,,,
,XCL1 gene|XCL1,,,Neoadjuvant Therapy,,Modified radical mastectomy,tamoxifen,Malignant neoplasm of breast,,,,,,,,,erbB-2 Receptor|ERBB2,,,"Clinical Trials, Phase II",,,,,,,,,,
,Obesity,,,Adriamycin,,Biopsy,tumor growth,Malignant neoplasm of breast,,,,,,,,,interleukin-10,,,Patients,,,,,,,,,,
,Mastectomy,,,Pharmacotherapy,,Woman,Cell Count,Diabetes,,,,,,,,,Poly(ADP-ribose) Polymerase Inhibitors,,,Selective Estrogen Receptor Modulators,,,,,,,,,,
,Patients,,,Proton Therapy,,Diagnosis,"Antigens, Neoplasm",Digital mammography,,,,,,,,,Neoadjuvant Chemotherapy,,,Intervention regimes,,,,,,,,,,
,Tamoxifen,,,pyrotinib,,Assessment procedure,Hormone Therapy,Ovarian Carcinoma,,,,,,,,,Pharmacotherapy,,,Intervention regimes,,,,,,,,,,
,Tamoxifen,,,Neoadjuvant Therapy,,Screening mammography,tumor growth,Patients,,,,,,,,,"Receptors, Progesterone",,,Aromatase Inhibitors,,,,,,,,,,
,Tamoxifen,,,Neoadjuvant Chemoradiotherapy,,Biopsy,interleukin-8,Patients,,,,,,,,,olaparib,,,Woman,,,,,,,,,,
,Alendronate,,,estrogens,,diagnostic procedure,interleukin-8,Magnetic Resonance Imaging,,,,,,,,,Neoadjuvant Chemotherapy,,,research,,,,,,,,,,
,Patients,,,Neoadjuvant Therapy,,Mammography,Malignant neoplasm of breast,Nipples,,,,,,,,,olaparib,,,Saline,,,,,,,,,,
,Aromatase Inhibitors,,,Bilateral mastectomy,,Patient identification,MYC,Blood Transfusion,,,,,,,,,lapatinib,,,oleuropein,,,,,,,,,,
,Internal mammary lymph node group,,,Work-up,,Cancer Treatment,ERBB3 Receptor Protein-Tyrosine Kinase|ERBB3,Intensity-Modulated Proton Therapy,,,,,,,,,"Receptors, Progesterone",,,Pharmacotherapy,,,,,,,,,,
,Disease,,,"Receptors, Progesterone",,Osteoporosis,Tumor Suppressor Genes,FOXJ2 gene|FOXJ2,,,,,,,,,Cell-Free DNA,,,Clinical Research,,,,,,,,,,
,Tamoxifen,,,Immunologic Adjuvants,,Patients,cryptotanshinone,Volumetric-Modulated Arc Therapy,,,,,,,,,sacituzumab govitecan,,,Woman,,,,,,,,,,
,Patients,,,Neoadjuvant Chemotherapy,,treatment program,Malignant neoplasm of breast,BRCA1 Gene Mutation,,,,,,,,,Secondary malignant neoplasm of viscera,,,Woman,,,,,,,,,,
,Noninfiltrating Intraductal Carcinoma,,,pyrotinib,,Woman,tamoxifen,Bilateral mastectomy,,,,,,,,,CDKN2A gene|CDKN2A,,,Decreased translucency,,,,,,,,,,
,Tamoxifen,,,Operation on breast,,"Image analysis, quantitative",Drug Delivery Systems,tamoxifen,,,,,,,,,Neoplasms,,,Woman,,,,,,,,,,
,Hereditary Malignant Neoplasm,,,Operation on breast,,Patients,Excitatory Amino Acids,Woman,,,,,,,,,First line treatment,,,Treatment Protocols,,,,,,,,,,
,BRCA1 gene|BRCA1,,,Palliative Care,,Institutes,"MCM3 protein, human|MCM3",Axilla,,,,,,,,,Pharmacotherapy,,,research,,,,,,,,,,
,Tamoxifen,,,Neoadjuvant Chemotherapy,,Mastectomy,tamoxifen,Axilla,,,,,,,,,Neoadjuvant Therapy,,,research,,,,,,,,,,
,Mammography,,,Conventional Imaging,,Diabetes,"Diabetes Mellitus, Non-Insulin-Dependent",Bilateral subcutaneous mammectomy,,,,,,,,,Triple Negative Breast Neoplasms,,,research,,,,,,,,,,
,desires,,,carboplatin,,Procedures,GA-Binding Protein Transcription Factor|GABPA|NFE2L2,Mammaplasty,,,,,,,,,Estrogen Antagonists,,,anastrozole,,,,,,,,,,
,Ovariectomy,,,Neoadjuvant Chemotherapy,,"Hospitals, General",BECN1 gene|BECN1,Mammaplasty,,,,,,,,,vinorelbine,,,Curcumin,,,,,,,,,,
,Mastectomy,,,Pharmacotherapy,,Procedures,Liquid Biopsy,Claudins,,,,,,,,,Metronomic Chemotherapy,,,Tumor Initiation,,,,,,,,,,
,Treatment Protocols,,,Biological Response Modifiers,,Procedures,"MCM3 protein, human|MCM3",Tomotherapy,,,,,,,,,doxorubicin,,,,,,,,,,,,,
,DMD|BEST1,,,trastuzumab,,Intervention regimes,exemestane,claudin 3,,,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,
,Diagnostic Imaging,,,First line treatment,,Malignant neoplasm of breast,Androgen Receptor,Malignant neoplasm of breast,,,,,,,,,Metronomic Chemotherapy,,,,,,,,,,,,,
,Obesity,,,docetaxel,,adjuvant therapy,Immunohistochemistry,"Neoplasms, Second Primary",,,,,,,,,Antibiotics,,,,,,,,,,,,,
,Mastectomy,,,Neoadjuvant Chemotherapy,,Psychosocial care,Systemic Therapy,Genetic Counseling,,,,,,,,,Pharmacotherapy,,,,,,,,,,,,,
,Electromagnetic Energy,,,Neoadjuvant Radiotherapy,,Assessment procedure,Interventional procedure,"Neoplastic Syndromes, Hereditary",,,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,
,Neurofibromatosis 1,,,Lymph node excision,,Mammography,SLC20A1 gene|SLC20A1,Radiation therapy,,,,,,,,,MKI67 gene|MKI67,,,,,,,,,,,,,
,Electromagnetic Energy,,,Mammaplasty,,Procedures,CDKN2A gene|CDKN2A,Pharmacotherapy,,,,,,,,,pembrolizumab,,,,,,,,,,,,,
,Single Nucleotide Polymorphism,,,Pharmacotherapy,,Malignant neoplasm of breast,cathepsin V,Woman,,,,,,,,,Pharmacotherapy,,,,,,,,,,,,,
,Endocrine therapy,,,"Radiotherapy, Adjuvant",,Symptoms,Clinical Treatment,Metaplastic carcinoma of breast,,,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,
,Radiation therapy,,,Mastectomy,,Magnetic Resonance Imaging,Hepatocyte Nuclear Factor 3-alpha|FOXA1,Medical Devices,,,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,
,Tamoxifen,,,Hypofractionated radiation therapy,,Contraction,Selective Estrogen Receptor Down Regulator,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,
,,,,Excision of skin,,Physical Examination,GATA3 gene|GATA3,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Specialty Group,GATA3 gene|GATA3,mass cystic,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Co-morbid conditions,ESR1 gene|ESR1,Macrophage Activation Syndrome,,,,,,,,,,,,,,,,,,,,,,
,,,,Mastectomy,,Clinic,cathepsin V,Proton Therapy,,,,,,,,,,,,,,,,,,,,,,
,,,,Mammaplasty,,Malignant neoplasm of breast,Tumor Suppressor Genes,Cancer-Predisposing Gene,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Health care facility,tamoxifen,Amyopathic dermatomyositis,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Therapeutic procedure,"CD69 protein, human|CD69",Drug Tapering,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Therapy,,Ambulatory Care Facilities,Tumor Suppressor Genes,Breast-Conserving Surgery,,,,,,,,,,,,,,,,,,,,,,
,,,,IMPACT gene,,Diagnosis,cryptotanshinone,Breast-Conserving Surgery,,,,,,,,,,,,,,,,,,,,,,
,,,,Local advancement flap,,Assessment procedure,estrogens,Intraoperative Radiation Therapy,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Intervention regimes,Tissue specimen,Intraoperative Radiation Therapy,,,,,,,,,,,,,,,,,,,,,,
,,,,Reconstructive Surgical Procedures,,Computer Aided Detection Systems,everolimus,Administration procedure,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Fracture,Wild Type,Intraoperative Radiation Therapy,,,,,,,,,,,,,,,,,,,,,,
,,,,Mammaplasty,,Osteoporosis,lysine,"CD69 protein, human|CD69",,,,,,,,,,,,,,,,,,,,,,
,,,,Membrane Transport Proteins,,Liver,Proliferation (morphologic abnormality),Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,
,,,,Patients,,Woman,Adjuvant Therapy,NODAL gene,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Mastectomy,Precision Medicine,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Second Primary Cancers,Lactates,,,,,,,,,,,,,,,,,,,,,,,
,,,,Operative Surgical Procedures,,Diet good,Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,SLC12A1 gene|SLC12A1,,Intervention regimes,Ovarian ablation,,,,,,,,,,,,,,,,,,,,,,,
,,,,Oncoplastic Partial Mastectomy/Lumpectomy with Oncoplastic Closure,,Magnetic Resonance Imaging,Cannabinoids,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Noninfiltrating Intraductal Carcinoma,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,Breast-Conserving Surgery,,Patients,Immunologic Adjuvants,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Malignant Neoplasms,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Therapy,,Pharmacotherapy,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Diagnosis,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,Volumetric-Modulated Arc Therapy,,Specialty Group,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,IMPACT gene,,Probes,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Nipple discharge NOS,Immunohistochemistry,,,,,,,,,,,,,,,,,,,,,,,
,,,,Partial Breast Irradiation,,Pharmacotherapy,inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,Breast-Conserving Surgery,,Odds Ratio,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Therapeutic procedure,inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Radiation therapy,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,Hypofractionated radiation therapy,,Psychotherapy,Systemic Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,"Radiotherapy, Adjuvant",,follow-up,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Operative Surgical Procedures,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Radiotherapy,,Hormone replacement therapy,Malignant neoplasm of breast,,,,,,,,,,,,,,,,,,,,,,,
,,,,Scintimammography,,Woman,sunitinib,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Therapeutic procedure,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,cadexomer iodine,,Psychotherapy,Systemic Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Screening procedure,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,Ki67 Measurement,,Death (finding),SEMA7A gene|SEMA7A,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemotherapy,,Pharmacotherapy,Estrogen Receptor Inhibitor [EPC],,,,,,,,,,,,,,,,,,,,,,,
,,,,Intravenous chemotherapy,,Breast neoplasm screening,inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,FDG-Positron Emission Tomography,,Screening procedure,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,PET/CT scan,,Malignant Neoplasms,Invasive Carcinoma,,,,,,,,,,,,,,,,,,,,,,,
,,,,Pneumocystis jiroveci pneumonia,,Malignant neoplasm of breast,SEMA7A gene|SEMA7A,,,,,,,,,,,,,,,,,,,,,,,
,,,,prednisolone,,Breast cancer metastatic,sanguinarine,,,,,,,,,,,,,,,,,,,,,,,
,,,,CDKN2A gene|CDKN2A,,Diagnosis,Flap Endonuclease-1,,,,,,,,,,,,,,,,,,,,,,,
,,,,letrozole,,Ultrasonography,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,Mastectomy,,follow-up,Anthracycline Antibiotics,,,,,,,,,,,,,,,,,,,,,,,
,,,,Breast-Conserving Surgery,,"Endometriosis, site unspecified",doxorubicin,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Chemoradiotherapy,,thermography,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,Neoadjuvant Therapy,,Mammography,Immunologic Adjuvants,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Fertility,chrysoeriol,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Consultation,"Radiosurgery, Stereotactic",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Emotional support,ponatinib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Preventive Intervention,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Mass Fragmentography,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Adenocarcinoma,apigenin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Woman,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Health System,Secondary Neoplasm,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Cancer Center,Biological Factors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Disease,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Indicators,CREB-binding protein|CREB1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Biopsy,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,adenoma,Estrogen Receptors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Diagnosis,Advanced Breast Carcinoma,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Therapeutic procedure,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Bariatric Surgery,Basis,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Multiple Sclerosis,MRTFA gene|MKL1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Tissue specimen,STAT3 gene|STAT3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Hospitals,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Early Diagnosis,Estrogen Receptor alpha,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Immunohistochemistry,Screening for cancer,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,follow-up,Immunologic Surveillance,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Radiation therapy,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Ultrasonography,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Diagnosis,CYP2D6 gene|CYP2D6,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Neuroendocrine Tumors,SLC5A1 gene|SLC5A1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Mammography,"EPHB2 protein, human|EPHB2",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Malignant neoplasm of prostate,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Imaging Device,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Patients,DUXAP8 gene|DUXAP8,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Woman,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Male population group,FOXD2-AS1 gene|FOXD2-AS1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Male population group,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Operative Surgical Procedures,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Mass Fragmentography,Operative Surgical Procedures,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Lung nodule,CDK4,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Malignant Neoplasms,IMPACT gene,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Supplementation,late endosome,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Endocrine therapy,Alpha tumour necrosis factor measurement,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Counseling,antagonists,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Brain Neoplasms,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Carrier of disorder,HOXA5 gene|HOXA5,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Computer Aided Detection Systems,Agent,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Woman,NUAK2 gene|NUAK2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,MASS LESION,removal technique,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Cardiovascular Diseases,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Screening procedure,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,advanced disease,LLGL2 gene|LLGL2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Cancer Control,EP300 gene|EP300,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Malignant neoplasm of breast,NR4A1 gene|NR4A1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,Diagnosis,OTUD7B gene|OTUD7B,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant neoplasm of breast,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CYP2D6 gene|CYP2D6,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Chemotherapy, Adjuvant",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,toremifene,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FGFR1 wt Allele|FGFR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Biological Response Modifiers,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Patients,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Sentinel Lymph Node Biopsy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,LINC00963 gene|LINC00963,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,NR4A1 gene|NR4A1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptor alpha,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,BCL2 gene|BCL2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Discoidin Domain Receptor 1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CD163,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Alpha tumour necrosis factor measurement,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FGFR1 wt Allele|FGFR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Breast-Conserving Surgery,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FGFR1 wt Allele|FGFR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"EPHB2 protein, human|EPHB2",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Antagonists,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Laboratory Procedures,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Gene Mutant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MAPT gene|MAPT,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"MEN1 protein, human|MEN1",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"estrogen receptor alpha, human",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,cyclophosphamide,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Crotoxin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,letrozole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,erbB-2 Receptor|ERBB2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Crotoxin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Infiltration,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,letrozole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Poly(ADP-ribose) Polymerase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptor alpha,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CDKN2A gene|CDKN2A,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Treatment Protocols,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,cyclophosphamide,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Breast-Conserving Surgery,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Carcinogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Therapeutic procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hypermethylation,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,STARD3 gene|STARD3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,WEE1 gene|WEE1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,alpelisib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Transformation, function",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fluorouracil,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,TALDO1 gene|TALDO1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,New medications,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Cancer-Predisposing Gene,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,epirubicin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptor Inhibitor [EPC],,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Patients,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Cerebrovascular accident,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptor alpha,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Coronary Arteriosclerosis,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Receptors, Progesterone",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,abemaciclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,XK gene|XK,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Histone Deacetylase,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Parity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Uveal melanoma,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,IMPACT gene,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,SLC39A6 gene|SLC39A6,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,LLGL2 gene|LLGL2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Magnetic Resonance Imaging,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Decreased drug resistance,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Polymerase chain reaction analysis,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Postoperative chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CDKN2A gene|CDKN2A,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,cytotoxicity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Diabetes Mellitus, Non-Insulin-Dependent",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,synaptotagmin XIII,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,HSD3B1 gene|HSD3B1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,SLC39A6 gene|SLC39A6,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Assay,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CDKN2A gene|CDKN2A,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant neoplasm of breast,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,thymidine kinase 1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"HGS protein, human|HGS",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Agent,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,COVID-19,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Therapeutic procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immune Checkpoint Proteins,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Infiltration,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immunologic Adjuvants,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptor alpha,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,IMPACT gene,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Large Neutral Amino Acid-Transporter 1|SLC7A5,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Steroidal estrogen preparation,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Selective Estrogen Receptor Down Regulator,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Poly(ADP-ribose) Polymerase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,HSF1 gene|HSF1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,isoeugenol,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Psychotherapy, Multiple",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Antineoplastic Agents,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Triglycerides,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,sphingosine 1-phosphate,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"FRAP1 protein, human|MTOR",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant neoplasm of stomach,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Oxidoreductase,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Detection,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,taxane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Disease,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Apoptosis Inhibiting Proteins,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,taxane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Selective Estrogen Receptor Modulators,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Treatment Protocols,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Targeted Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PET/CT scan,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CDC42,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fatostatin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,hepatitis B virus X protein,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Ovarian ablation,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,mRNA editing,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,TP53,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,elacestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Promoters,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MED1 gene|MED1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,hepatitis B virus X protein,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,B-Cell Leukemia 2 Family Proteins,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fluorouracil,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Parity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CDK7 gene|CDK7,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,quiescence,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,biochanin A,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,TP53,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CDK7 gene|CDK7,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Duration,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,antagonists,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Androgen Receptor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FDG-Positron Emission Tomography and Computed Tomography Scan,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MDM2 gene|MDM2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Poly(ADP-ribose) Polymerase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Stat3 protein,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,osteopontin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Gold Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,palbociclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GATA3 gene|GATA3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Excision of axillary lymph nodes group,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Biological Response Modifiers,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GZMK gene|GZMK,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Observation - diagnostic procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PET/CT scan,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Selective Estrogen Receptor Down Regulator,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PET/CT scan,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ROS1 wt Allele|ROS1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,APBB1 gene|APBB1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Palliative Care,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,APBB1 gene|APBB1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Environmental Estrogen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Application procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tamoxifen therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Stat3 protein,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GZMK gene|GZMK,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hypersensitivity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Cyclin-Dependent Kinase 4,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MDM2 gene|MDM2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Large Neutral Amino Acid-Transporter 1|SLC7A5,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Receptors, Progesterone",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GATA3 gene|GATA3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Secondary malignant neoplasm of vertebral column,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PET/CT scan,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Patients,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,osteopontin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Acne,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FMNL2 gene|FMNL2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Excision of axillary lymph nodes group,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,cholesterol,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adrenal Gland Hyperfunction,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Procedure findings:Finding:Point in time:^Patient:Narrative,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GATA3 gene|GATA3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Antagonists,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,letrozole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Mandibular left second molar abutment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,TP53,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hypersensitivity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immunologic Adjuvants,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Binding Proteins,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Chemotherapy, Adjuvant",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MYCBP2 gene|MYCBP2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,andrographolide,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Laboratory Procedures,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Primary Neoplasm,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RNA Sequence,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ESR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Insulin Receptor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,anastrozole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Phosphotransferases,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,imipramine,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,NNAT gene|NNAT,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Recurrent disease,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,andrographolide,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,NNAT gene|NNAT,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Antagonists,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MYCT1 gene|MYCT1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Mandibular left second molar abutment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Phosphotransferases,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,calcium,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PET/CT scan,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Interferon Type I,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ESR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Cell Count,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Core needle biopsy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,abemaciclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RUNX1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Exosomes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MDM2 gene|MDM2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Bombesin Receptor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tumor growth,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ECM1 gene|ECM1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,HSD3B1 gene|HSD3B1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,COL11A1 gene|COL11A1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Amcenestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Receptors, Progesterone",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MTOR gene|MTOR,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ECM1 gene|ECM1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GATA3 gene|GATA3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pathogenic Variant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ECM1 gene|ECM1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,iron,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Obesity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Disease,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FOXM1 wt Allele,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Biological Response Modifiers,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,H19 gene|H19|HILS1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,elacestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"E2F1 protein, human|E2F1|UBE2L3",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Triple Negative Breast Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,cholecalciferol,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Single Agent Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,abemaciclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Psychotherapy, Multiple",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ESR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,genetic element,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MCF-7 Cells,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Enhancer of Zeste Homolog 2 Protein,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,HSD3B1 gene|HSD3B1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrus,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Combined Modality Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FOSB,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,carbidopa,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FGFR Inhibitor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Lipopolysaccharides,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Lipoprotein (a),,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Selective Estrogen Receptor Modulators,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ATF3 gene|ATF3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fatostatin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Proto-Oncogene c-Fos, human|FOS",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,palbociclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Fibroblast Growth Factor Receptor 1|FGFR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,carbidopa,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,palbociclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"TRIM25 protein, human|TRIM25",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,palbociclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Psychotherapy, Multiple",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Transforming Growth Factor beta Receptors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Oncogene Proteins,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,palbociclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,dexamethasone,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,BRCA2 gene|BRCA2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Breast-Conserving Surgery,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Poly(ADP-ribose) Polymerase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,naltrexone,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,NUS1 gene|NUS1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,DIO3OS gene|DIO3OS,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GJA1 gene|GJA1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"CD69 protein, human|CD69",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estradiol,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RCOR1 gene|RCOR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,USP37 gene|USP37,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ANTXR2 gene|ANTXR2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Oral intake,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,indocyanine green,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,everolimus,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,4-hydroxy-N-desmethyltamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Giredestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body mass index procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,lysosomal Pro-X carboxypeptidase,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Infiltration,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Assay,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Opioid Receptor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,NUS1 gene|NUS1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Inhibitor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body mass index procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,everolimus,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Agent,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogenic,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Mastectomy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Conventional Treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,indocyanine green,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,SMUG1 gene|SMUG1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ceramide kinase,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Tomography, Emission-Computed",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,navitoclax,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CHEK2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ESR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Metabolic marker,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PDCD1 gene|PDCD1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,AKTIP gene|AKTIP,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Selective Estrogen Receptor Down Regulator,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,alpelisib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,alpelisib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Chemotherapy, Adjuvant",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Selective Estrogen Receptor Modulators,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Ki67 Measurement,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,AKTIP gene|AKTIP,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RBCK1 gene|RBCK1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Fresh Tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RNF31 gene|RNF31,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Combined Modality Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"RNA, Small Interfering",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Disease Progression,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Coordination Complexes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Proliferation (morphologic abnormality),,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ROS1 wt Allele|ROS1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Woman,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,anastrozole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Histone deacetylase inhibitor|HDAC9,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,dioscin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,protodioscin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Vigorous physical activity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,antagonists,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Conventional Imaging,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Phosphoglycerate dehydrogenase,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Androgen Receptor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,novel AODU treatment method,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Transection (procedure),,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Agent,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Androgen Receptor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Ovariectomy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogen receptor-negative breast cancer,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Open Reading Frames,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Endocrine Disruptors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,IMPACT gene,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,High Level,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Current Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PET/CT scan,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Dietary Intake,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Puberty,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hypoxia,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,SRSF5 gene|SRSF5,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Microenvironment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"PTGS2 protein, human|PTGS2",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Drug resistance,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Selective Estrogen Receptor Down Regulator,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Conventional Treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immunologic Adjuvants,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CDKN2A gene|CDKN2A,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Regulatory Sequences, Nucleic Acid",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Prophylactic treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"PTGS2 protein, human|PTGS2",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,XBP1 gene|XBP1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Inflammatory Breast Carcinoma,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Nitric Oxide Synthase Type II|NOS2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Microenvironment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,XBP1 gene|XBP1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Positron Emission Tomography and Magnetic Resonance Imaging,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,BARRIER,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fulvestrant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FDG-Positron Emission Tomography,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Positron-Emission Tomography,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,nicotinamide adenine dinucleotide (NAD),,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Nitric Oxide Synthase Type II|NOS2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Tomography, Emission-Computed",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,DLD gene|DLD,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,vitamin E,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,NNAT gene|NNAT,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Antineoplastic Agents,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,p21-Activated Kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,p21-Activated Kinase 1|CDKN1A|TCEAL1|NSG1|H3F3AP6,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Exploration procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Methylnitrosourea,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Primary Neoplasm,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Application procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GJA1 gene|GJA1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"CD274 protein, human|CD274",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,receptor for advanced glycation endproducts,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,LINC02568 gene|LINC02568,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ESR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,LINC02568 gene|LINC02568,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GJA1 gene|GJA1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Thrombomodulin,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Cells,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,NNAT gene|NNAT,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Subtyping,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Primary Neoplasm,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CITED1 gene|CITED1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Positron-Emission Tomography,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Protein Expression Analysis,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adenocarcinoma in Situ,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,garlic preparation,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adenocarcinoma in Situ,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Obesity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RET,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Noninfiltrating Intraductal Carcinoma,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,anastrozole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MAGI1 gene|MAGI1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GATAD1 gene|GATAD1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Carcinogenesis,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MicroRNAs,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Peptide Hydrolases,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PRMT5 gene|PRMT5,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,GATAD1 gene|GATAD1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FOXA1 gene|FOXA1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,riluzole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,anastrozole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Anastrozole/Palbociclib Regimen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Gene Feature,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Second line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,anastrozole,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CAV1 gene|CAV1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Freund's Adjuvant,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,SPATA13 gene|SPATA13,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogen receptor-negative breast cancer,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,everolimus,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,First line treatment,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,exemestane,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Transcription Repressor/Corepressor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Obesity,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"ATF2 protein, human|ATF2",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,KAT6A gene|KAT6A,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Receptors, Opioid, kappa",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Dried fruit intake,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Extended Rotated Sidebent,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Fulvestrant/Palbociclib Regimen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Positive Regulation of Oxidative Stress Process,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Androgens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,TBATA gene|TBATA,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Menopause,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Infiltration,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Liquid Biopsy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Single Nucleotide Polymorphism,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Toxic Epidermal Necrolysis,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Adjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Cytokine Gene,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Triple Negative Breast Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,SNAI2 gene|SNAI2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RFC3 gene|RFC3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Nitric Oxide Synthase Type II|NOS2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,cathepsin V,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,XBP1 gene|XBP1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estradiol,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Chemotherapy, Adjuvant",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CCN1 gene|CCNA2|CYR61|PPP3CA,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Nitric Oxide Synthase,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CCN1 gene|CCNA2|CYR61|PPP3CA,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RFC3 gene|RFC3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Single Agent Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"PTGS2 protein, human|PTGS2",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immunologic Adjuvants,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptor alpha,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Woman,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,fluorodeoxyglucose F18,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,cathepsin V,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Autophagy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Breast-Conserving Surgery,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Prostaglandin-Endoperoxide Synthase,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ESR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Estrogen Receptor alpha,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immunologic Adjuvants,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Gene Feature,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immune Checkpoint Inhibitors,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant neoplasm of breast,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Biopsy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,HMGCR gene|HMGCR,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Therapeutic procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Proteins,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Biological Response Modifiers,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant neoplasm of breast,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PRMT5 gene|PRMT5,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RFWD3 gene|RFWD3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Therapeutic procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,COL11A1 gene|COL11A1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Apolipoprotein A-I|APOA1|LPA,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Assay,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Photochemotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Therapeutic procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FOXC1 gene|FOXC1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,COL11A1 gene|COL11A1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ESR1,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MIR190B gene|MIR190B,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Androgens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,ELAVL2 gene|ELAVL2,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,RFWD3 gene|RFWD3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Biological Response Modifiers,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immunologic Adjuvants,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,progesterone,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,estrogens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,palbociclib,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Crohn Disease,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"ORF74 protein, Human herpesvirus 8",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Interferons,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Breast-Conserving Surgery,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Cell Adhesion Molecules,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Selective Estrogen Receptor Down Regulator,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,SOX10 gene|SOX10,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Androgens,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MIR190B gene|MIR190B,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,novel AODU treatment method,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,tamoxifen,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Tumor Suppressor Genes,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,WDR3 gene|WDR3,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Inhibitor,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,PDE1B gene|PDE1B,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,MIR190B gene|MIR190B,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CYTOR gene|CYTOR,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Apoptosis,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Alzheimer's Disease,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"FRAP1 protein, human|MTOR",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"RNA, Long Untranslated",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Immunohistochemistry,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Hormone Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Elevation procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant neoplasm of breast,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Sphingolipids,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmacotherapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoplasms,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"Chemotherapy, Adjuvant",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Pharmaceutical Preparations,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,phosphatidylethanolamines,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Targeted Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoadjuvant Therapy,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant neoplasm of breast,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Neoplastic Cell Transformation,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Molecular Target,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Multiple Sclerosis,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FGFR4,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Increased risk,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Antineoplastic Agents,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,FGFR4,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,CATHEPSIN D,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,S100A11,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Body tissue,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Malignant neoplasm of thyroid,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Alzheimer's Disease,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Therapeutic procedure,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,"PIK3CB protein, human|PIK3CB",,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,Secondary Neoplasm,,,,,,,,,,,,,,,,,,,,,,,
